FHIR © HL7.org  |  Server Home  |  XIG Home  |  Server Source  |  FHIR  

FHIR IG Statistics: CodeSystem/v3-NullFlavor

Packagehl7.terminology.r4b
TypeCodeSystem
Idv3-NullFlavor
FHIR VersionR4B
Sourcehttp://terminology.hl7.org/http://terminology.hl7.org/6.0.2/CodeSystem-v3-NullFlavor.html
URLhttp://terminology.hl7.org/CodeSystem/v3-NullFlavor
Version3.0.0
Statusactive
Date2019-03-20
NameNullFlavor
TitleNullFlavor
Realmuv
Authorityhl7
DescriptionA collection of codes specifying why a valid value is not present.
CopyrightThis material derives from the HL7 Terminology THO. THO is copyright ©1989+ Health Level Seven International and is made available under the CC0 designation. For more licensing information see: https://terminology.hl7.org/license.html
Contentcomplete

Resources that use this resource

CodeSystem
null-flavor-csNull Flavor translations
translationNullFlavorÜbersetzung NullFlavor
ConceptMap
CertifierTypesCMCertifierTypes Concept Map
ContributoryTobaccoUseCMContributoryTobaccoUse Concept Map
DeathPregnancyStatusCMPregnancyStatus Concept Map
MethodOfDispositionCMMethodOfDisposition Concept Map
PlaceOfDeathCMPlaceOfDeath Concept Map
PlaceOfInjuryCMPlaceOfInjury Concept Map
SpouseAliveCMSpouseAlive Concept Map
TransportationIncidentRoleCMTransportationIncidentRole Concept Map
maritalstatus-ech11-to-fhirMaritalStatus eCH-011 to FHIR mapping
ConceptMapBirthAttendantTitlesVitalRecordsBirthAttendantTitles Concept Map
ConceptMapBirthSexChildVitalRecordsBirthSex Concept Map
ConceptMapBirthSexFetusVitalRecordsBirthSex Concept Map
ConceptMapEducationLevelVitalRecordsEducationLevel Concept Map
ConceptMapHispanicNoUnknownVitalRecordsHispanicNoUnknown Concept Map
ConceptMapMaritalStatusVitalRecordsMaritalStatus Concept Map
ConceptMapRaceMissingValueReasonVitalRecordsRaceMissingValueReason Concept Map
ConceptMapUnitsOfAgeVitalRecordsUnitsOfAge Concept Map
ConceptMapYesNoNotApplicableVitalRecordsNotApplicable Concept Map
ConceptMapYesNoUnknownNotApplicableVitalRecordsYesNoUnknownNotApplicable Concept Map
ConceptMapYesNoUnknownVitalRecordsYesNoUnknown Concept Map
ConceptMap-statoCivileMapping fra VS HL7 e Tabella ISTAT Stato Civile
CF-NullFlavorDataAbsentReasonC-CDA NullFlavor to FHIR Data Absent Reason
FC-DataAbsentReasonNullFlavorFHIR Data Absent Reason to C-CDA NullFlavor
FC-ProcedureStatusFHIR to C-CDA Procedure Status
ConceptMap-languageNZ Central Region Language Concept Map
ConceptMap-marital-statusNZ Central Region Marital Status Concept Map
table-hl70002-to-v3-maritalstatusTable HL70002 to V3 MaritalStatus Map
BirthAttendantTitlesCMBirthAttendantTitles Concept Map
BirthDeliveryOccurredCMBirthDeliveryOccurred Concept Map
FetalDeathCauseOrConditionCMFetalDeathCauseOrCondition Concept Map
FetalDeathTimePointsCMFetalDeathTimePoints Concept Map
FetalPresentationCMFetalPresentation Concept Map
KBV_CM_Base_Terminology_Complete_GermanKBV_CM_Base_Terminology_Complete_German
AllergieCategorieCodelijst-to-AllergyIntoleranceCategoryAllergieCategorieCodelijst to AllergyIntoleranceCategory
ContactTypeCodeLijst-to-ActEncounterCodeContactTypeCodeLijst to ActEncounterCode
GeslachtCodelijst-to-AdministrativeGenderGeslachtCodelijst to AdministrativeGender
NaamgebruikCodelijst-to-HumanNameAssemblyOrderNaamgebruikCodelijst to HumanNameAssemblyOrder
VerificatieStatusCodelijst-to-ConditionVerificationStatusVerificatieStatusCodelijst to ConditionVerificationStatus
BeCivilstate-to-MaritalStatusBeCivilstate_to_MaritalStatus
NameUsage-to-HumanNameAssemblyOrderNameUsage_to_HumanNameAssemblyOrder
CategorieCodelijst-to-AllergyIntoleranceCategoryCategorieCodelijst to AllergyIntoleranceCategory
ConceptMap-statoCivileMapping fra VS HL7 e Tabella ISTAT Stato Civile
ValueSet
VRM-CertAvailable-vsCertificate Available Values
VRM-PregnancyOutcomes-vsPregnancy Outcome Values
birthsexBirth Sex
CDANullFlavorCDANullFlavor
marital-status-vsMarital status translations
vrdr-activity-at-time-of-death-vsActivity at Time of Death ValueSet
vrdr-certifier-types-vsCertifier Types Value Set
vrdr-contributory-tobacco-use-vsContributory Tobacco Use ValueSet
vrdr-death-pregnancy-status-vsDeath Pregnancy Status ValueSet
vrdr-method-of-disposition-vsMethod of Disposition ValueSet
vrdr-place-of-death-vsPlace of Death ValueSet
vrdr-place-of-injury-vsPlace of Injury ValueSet
vrdr-spouse-alive-vsSpouse Alive ValueSet
vrdr-transportation-incident-role-vsTransportation Incident Role ValueSet
ValueSet-birth-attendant-titles-vrValue Set - Birth Attendants Titles Vital Records
ValueSet-education-level-vrValue Set - Education Level Vital Records
ValueSet-marital-status-vrValue Set - Marital Status Vital Records
ValueSet-race-missing-value-reason-vrValue Set - Race Missing Value Reason Vital Records
ValueSet-sex-assigned-at-birth-vrValue Set - Sex Assigned At Birth Vital Records
ValueSet-units-of-age-vrValue Set - Units of Age Vital Records
ValueSet-yes-no-not-applicable-vrValue Set - Yes No Not Applicable Vital Records
ValueSet-yes-no-unknown-not-applicable-vrValue Set - Yes No Unknown NotApplicable Vital Records
ValueSet-yes-no-unknown-vrValue Set - Yes No Unknown Vital Records
mcode-radiotherapy-modality-vsRadiotherapy Modality Value Set
mcode-radiotherapy-technique-vsRadiotherapy Technique Value Set
be-civilstateBeCivilState
be-vs-vaccination-administration-routeBeVSVaccineAdministrationRoute
PrimaryCarerParentGrandparentPrimary Carer Of Parent Or Grandparent
vs-affectedOrgan-eu-i4rcAffected Organs (surgery)
istat-provinciaISTAT - Province
statoCivileStato Civile
statoEsenzioneStato Esenzione
gender-identityGender Identity
v3-AskedButUnknownAskedButUnknown
v3-ClassNullFlavorClassNullFlavor
v3-NoInformationNoInformation
v3-NullFlavorNullFlavor
v3-OtherOther
v3-UnknownUnknown
yes-no-unknown-not-applicableYes No Unknown NotApplicable
AxillaSurgeryVSAxilla surgery ValueSet
BreastSurgeryTypeVSTypes of breast surgery ValueSet
ChemoTherapyTypeVSType of chemotherapy ValueSet
ComplicationImpactVSImpact of complication ValueSet
ComplicationTypeVSType of complication ValueSet
EstrogenStatusVSEstrogen receptor status ValueSet
GermlineMutationVSGermline Mutation ValueSet
GradingVSGrading of tumor ValueSet
HistologicalTypeVSHistological type of the tumor ValueSet
HormonalTherapyTypeVSType of hormonal therapy ValueSet
InvolvedMarginsReoperationTypeVSRe-operation due to involved margins ValueSet
LocationRadiotherapyVSThe location of radiotherapy ValueSet
MenopausalStatusVSMenopausal status of patient ValueSet
PatientTreatPrefVSPatient treatment preference ValueSet
ProgesteroneStatusVSProgesterone receptor status ValueSet
ReconstructionTypeVSType of reconstruction surgery ValueSet
RecurrenceMethodVSRecurrence method ValueSet
RecurrenceVSRecurrence of neoplasm ValueSet
RelationshipStatusVSRelationship status of patient ValueSet
ReoperationReasonVSReasoncode of the re-operation
ReoperationTypeVSType of re-operation
SACQPatientComorbidityHistorySACQ Patient's comorbidity history ValueSet
TNMDistantMetastasesVSTNM Distant Metastases ValueSet
TNMPrimaryTumorVSTNM Primary Tumor ValueSet
TNMRegionalNodesVSTNM Regional Nodes ValueSet
TargetedAxillaSurgeryVSTargeted axilla surgery ValueSet
TargetedTherapyVSType of targeted therapy ValueSet
TherapyIntentVSIntent of therapy ValueSet
TreatmentPlanNotFollowedVSTreatment Plan Not Followed ValueSet
TreatmentTypeVSType of treatments ValueSet
us-ph-pregnancy-statusUS Public Health Pregnancy Status
medcom-core-PractitionerRolesMedComCorePractitionerRoles
IHE.PCC.mPSC.DataAbsentReason.VSIHE PCC mPSC Data Absent Reason Value Set
SDOHCC-ValueSetObservationMethodSDOHCC ValueSet Observation Method
SDOHCC-ValueSetPronounsValueSDOHCC ValueSet Pronouns Value
ValueSet-allergy-reactionNZ Central Region - Allergy Reaction Value Set
ValueSet-flag-alert-codeNZ Central Region - Flag Alert Code Value Set
ValueSet-hospital-codeNZ Central Region - Hospital Value Set
ValueSet-languageNZ Central Region - Language Value Set
ValueSet-marital-statusNZ Central Region - Marital Status Value Set
DocReasonCRD Coverage Information Documentation Reason Value Set
informationNeededCRD Information Needed Value Set
be-civilstateBeCivilState
loinc-pregnancy-intent-codeLOINC + HL7 NullFlavor妊娠計畫值集
snomed-pregnancy-status-codeSNOMED CT + HL7 NullFlavor妊娠狀態值集
snomed-sexual-orientation-codeSNOMED CT + HL7 NullFlavor 性傾向值集
us-ph-valueset-pregnancy-statusUS Public Health VaueSet - Pregnancy Status
ValueSet-birth-attendant-titlesBirth Attendants Titles
ValueSet-birth-delivery-occurredBirth Delivery Occurred
ValueSet-fetal-death-cause-or-conditionFetal Death Cause or Condition
ValueSet-fetal-death-time-pointsFetal Death Time Points
ValueSet-fetal-presentationsFetal Presentations
ValueSet-fetal-remains-disposition-methodFetal Remains Disposition Method
ValueSet-infections-during-pregnancy-live-birthInfections During Pregnancy Live Birth
ValueSet-newborn-congenital-anomaliesNewborn Congenital Anomalies
AxillaSurgeryVSAxilla surgery ValueSet
BreastSurgeryTypeVSTypes of breast surgery ValueSet
ChemoTherapyTypeVSType of chemotherapy ValueSet
ComplicationImpactVSImpact of complication ValueSet
ComplicationTypeVSType of complication ValueSet
EstrogenStatusVSEstrogen receptor status ValueSet
GermlineMutationVSGermline Mutation ValueSet
GradingVSGrading of tumor ValueSet
HistologicalTypeVSHistological type of the tumor ValueSet
HormonalTherapyTypeVSType of hormonal therapy ValueSet
InvolvedMarginsReoperationTypeVSRe-operation due to involved margins ValueSet
LocationRadiotherapyVSThe location of radiotherapy ValueSet
MenopausalStatusVSMenopausal status of patient ValueSet
PatientTreatPrefVSPatient treatment preference ValueSet
ProgesteroneStatusVSProgesterone receptor status ValueSet
ReconstructionTypeVSType of reconstruction surgery ValueSet
RecurrenceMethodVSRecurrence method ValueSet
RecurrenceVSRecurrence of neoplasm ValueSet
RelationshipStatusVSRelationship status of patient ValueSet
ReoperationReasonVSReasoncode of the re-operation
ReoperationTypeVSType of re-operation
SACQPatientComorbidityHistorySACQ Patient's comorbidity history ValueSet
TNMDistantMetastasesVSTNM Distant Metastases ValueSet
TNMPrimaryTumorVSTNM Primary Tumor ValueSet
TNMRegionalNodesVSTNM Regional Nodes ValueSet
TargetedAxillaSurgeryVSTargeted axilla surgery ValueSet
TargetedTherapyVSType of targeted therapy ValueSet
TherapyIntentVSIntent of therapy ValueSet
TreatmentPlanNotFollowedVSTreatment Plan Not Followed ValueSet
TreatmentTypeVSType of treatments ValueSet
us-core-documentreference-typeUS Core DocumentReference Type
ValueSet-yes-no-not-applicableValueSet - Yes No NotApplicable
name-assembly-orderHumanNameAssemblyOrder
fmc-sexual-orientation-vsFresenius Sexual Orientation Value Set
NICE-AdministrationRouteNICE-AdministrationRoute
NICE-AdmitSourceNICE-AdmitSource
NICE-ContactTypeNICE-ContactType
NICE-DischargeDispositionNICE-DischargeDisposition
NICE-TreatmentCodelistNICE-TreatmentCodelist
MedikationsplanPlusPregnancystatusMedikationsplanPlusVSPregnancystatus
answerSetAcuteHBVDAnwort akute Infektion aufgrund wessen bei Hepatitis B
answerSetAcuteHCVDAnwort akute Infektion aufgrund wessen bei Hepatitis C
answerSetBeforeOrAfter1991Anwort Vor oder nach 1991
answerSetCauseDiagnosisMYTDAnwort Anlass der Diagnose bei Tuberkulose
answerSetCoinfectionHDVDAnwort Koinfektion mit Hepatitis B bei Hepatitis D
answerSetConservationCLODAntwort zur Art der Lebensmittelkonservierung bei Botulismus
answerSetConsumptionCLODAntwort zum Ort des Verzehrs bei Botulismus
answerSetCountryAnwort Country mit staatenlos und Ausland
answerSetDiagnosisCJKDAntwortmöglichkeiten für die Angabe der Ausprägung des Meldetatbestands "Creutzfeldt-Jakob-Krankheit (CJK)"
answerSetFoodCLODAntwort zum verzehrten Lebensmittel bei Botulismus
answerSetFormBANDAntwortmöglichkeiten für die Angabe der Ausprägung des Meldetatbestands "Milzbrand"
answerSetFormCDFDAntwortmöglichkeiten für die Angabe der Ausprägung des Meldetatbestands "Clostridioides-difficile-Erkrankung, schwere Verlaufsform"
answerSetFormCJKDAntwortmöglichkeiten für die Angabe der Ausprägung des Meldetatbestands "Creutzfeldt-Jakob-Krankheit (CJK)"
answerSetFormCLODAntwortmöglichkeiten für die Angabe der Ausprägung des Meldetatbestands "Botulismus"
answerSetFormCORDAntwortmöglichkeiten für die Angabe der Ausprägung des Meldetatbestands "Diphtherie"
answerSetFormMYBDAntwortmöglichkeiten für die Angabe der Ausprägung des Meldetatbestands "Tuberkulose, bei Behandlungsabbruch"
answerSetFormYPSDAntwortmöglichkeiten für die Angabe der Ausprägung des Meldetatbestands "Pest"
answerSetGeographicRegionAntwort geographische Region
answerSetHospitalizationReasonAntwort Grund der Hospitalisierung
answerSetInfectionAnimalWhereHUSDAnwort Tierkontakt wo bei Hämolytisch-urämisches Syndrom (HUS)
answerSetInfectionEnvironmentSettingCVDDAntwortmöglichkeiten zur Angabe des Infektionsumfelds bei dem Meldetatbestand "Coronavirus-Krankheit-2019 (COVID-19)"
answerSetInfectionEnvironmentSettingMYTDAntwortmöglichkeiten zur Angabe des Infektionsumfelds bei dem Meldetatbestand "Tuberkulose"
answerSetInfectionPathCJKDAntwortmöglichkeiten zur Angabe des Infektionswegs bei dem Meldetatbestand "Creutzfeldt-Jakob-Krankheit (CJK)"
answerSetInfectionPathHAVDAntwortmöglichkeiten zur Angabe des Infektionswegs bei dem Meldetatbestand "Hepatitis A"
answerSetInfectionPathHBVDAntwortmöglichkeiten zur Angabe des Infektionswegs bei dem Meldetatbestand "Hepatitis B"
answerSetInfectionPathHCVDAntwortmöglichkeiten zur Angabe des Infektionswegs bei dem Meldetatbestand "Hepatitis C"
answerSetInfectionPathHEVDAntwortmöglichkeiten zur Angabe des Infektionswegs bei dem Meldetatbestand "Hepatitis E"
answerSetInfectionPathHUSDAntwortmöglichkeiten zur Angabe des Infektionswegs bei dem Meldetatbestand "Hämolytisch-urämisches Syndrom (HUS)"
answerSetInfectionPathIZVDAntwortmöglichkeiten zur Angabe des Infektionswegs bei dem Meldetatbestand "Zoonotische Influenza"
answerSetInfectionPathMPXDAntwortmöglichkeiten zur Angabe des Infektionswegs bei dem Meldetatbestand "Mpox"
answerSetInfectionPathOPXDAntwortmöglichkeiten zur Angabe des Infektionswegs bei dem Meldetatbestand "Orthopocken, andere"
answerSetInfectionPathWhoHUSDAntwortmöglichkeiten zur Angabe der Person, bei der sich infiziert wurde, bei dem Meldetatbestand "Hämolytisch-urämisches Syndrom (HUS)"
answerSetInfectionRiskAnimalHEVDAntwort zu Tierkontakt bei Hepatitis E
answerSetInfectionRiskAnimalHUSDAntwort zu Tierkontakt bei Hämolytisch-urämisches Syndrom (HUS)
answerSetInfectionRiskAnimalRBVDAntwort zu Tierkontakt bei Tollwut
answerSetInfectionRiskAnimalTTVDAntwort zu Tierkontakt bei Tollwutexpositionsverdacht
answerSetInfectionRiskCVDDAntwortmöglichkeiten für die Angabe der Risikofaktoren in Zusammenhang mit dem Meldetatbestand "Coronavirus-Krankheit-2019 (COVID-19)"
answerSetInfectionRiskIZVDAntwortmöglichkeiten für die Angabe der Risikofaktoren in Zusammenhang mit dem Meldetatbestand "Zoonotische Influenza"
answerSetInfectionRiskJobHEVDAntwortmöglichkeiten für die Angabe der beruflichen Risiken in Zusammenhang mit dem Meldetatbestand "Hepatitis E"
answerSetInfectionRiskJobHTVDAntwortmöglichkeiten für die Angabe der beruflichen Risiken in Zusammenhang mit dem Meldetatbestand "Hantavirus-Erkrankung, hämorrhagischer Verlauf"
answerSetInfectionRiskNEIDAntwortmöglichkeiten für die Angabe der Risikofaktoren in Zusammenhang mit dem Meldetatbestand "Meningokokken, invasive Erkrankung"
answerSetInfectionRiskOtherHEVDAntwort zu Sonstiger Kontakt bei Hepatitis E
answerSetLocationLymphNodeSwellingMPXDAnwort Lokalisation der Lymphknotenschwellung bei Mpox
answerSetLocationMucosalLesionsMPXDAnwort Lokalisation der Schleimhautläsionen bei Mpox
answerSetLocationSkinLesionsMPXDAnwort Lokalisation der Hautläsionen bei Mpox
answerSetMajorSiteMYTDAnwort hauptsächlich betroffenes Organ bei Tuberkulose
answerSetManufacturingCLODAntwort zur Art der Lebensmittelherstellung bei Botulismus
answerSetMethodCDFDAntwortmöglichkeiten für die Angabe der Nachweismethode der Clostridioides-difficile-Erkrankung, schwere Verlaufsform
answerSetMilitaryAffiliationAntwort Zugehörigkeit zur Bundeswehr
answerSetMinorSiteMYTDAnwort weiteres betroffenes Organ bei Tuberkulose
answerSetPathogenHFADAntwortmöglichkeiten zur Angabe des Erregers bei dem Meldetatbestand "Hämorrhagisches Fieber"
answerSetPregnancyWeekAnwort Schwangerschaftswoche
answerSetResultOfPrevTreatmentMYTDAnwort Ergebnis der Vorbehandlung bei Tuberkulose
answerSetResultOfTreatmentMYTDAnwort Behandlungsergebnis bei Tuberkulose
answerSetStadiumHBVDAnwort Stadium der Infektion bei Hepatitis B
answerSetStadiumHCVDAnwort Stadium der Infektion bei Hepatitis C
answerSetTransmissionKindHBVDAntwortmöglichkeiten für nosokomiale Übertragung bei Hepatitis B
answerSetTransmissionKindHCVDAntwortmöglichkeiten für nosokomiale Übertragung bei Hepatitis C
answerSetTrimesterAntwort zum Trimester
nullFlavorNullFlavor
vaccineBANDAntwortmöglichkeiten für die Angabe des Impfstoffs in Bezug auf den Meldetatbestand "Milzbrand"
vaccineBPSDAntwortmöglichkeiten für die Angabe des Impfstoffs in Bezug auf den Meldetatbestand "Keuchhusten"
vaccineCDFDAntwortmöglichkeiten für die Angabe des Impfstoffs in Bezug auf den Meldetatbestand "Clostridioides-difficile-Erkrankung, schwere Verlaufsform"
vaccineCORDAntwortmöglichkeiten für die Angabe des Impfstoffs in Bezug auf den Meldetatbestand "Diphtherie"
vaccineDENDAntwortmöglichkeiten für die Angabe des Impfstoffs in Bezug auf den Meldetatbestand "Denguefieber"
vaccineEBVDAntwortmöglichkeiten für die Angabe des Impfstoffs in Bezug auf den Meldetatbestand "Ebolafieber"
vaccineGFVDAntwortmöglichkeiten für die Angabe des Impfstoffs in Bezug auf den Meldetatbestand "Gelbfieber"
vaccineHAVDAntwortmöglichkeiten für die Angabe des Impfstoffs in Bezug auf den Meldetatbestand "Hepatitis A"
vaccineHBVDAntwortmöglichkeiten für die Angabe des Impfstoffs in Bezug auf den Meldetatbestand "Hepatitis B"
vaccineHDVDAntwortmöglichkeiten für die Angabe des Impfstoffs in Bezug auf den Meldetatbestand "Hepatitis D"
vaccineHEVDAntwortmöglichkeiten für die Angabe des Impfstoffs in Bezug auf den Meldetatbestand "Hepatitis E"
vaccineHXXDAntwortmöglichkeiten für die Angabe des Impfstoffs in Bezug auf den Meldetatbestand "Akute Virushepatitis"
vaccineIZVDAntwortmöglichkeiten für die Angabe des Impfstoffs in Bezug auf den Meldetatbestand "Zoonotische Influenza"
vaccineMPVDAntwortmöglichkeiten für die Angabe des Impfstoffs in Bezug auf den Meldetatbestand "Mumps"
vaccineMPXDAntwortmöglichkeiten für die Angabe des Impfstoffs in Bezug auf den Meldetatbestand "Mpox"
vaccineMSVDAntwortmöglichkeiten für die Angabe des Impfstoffs in Bezug auf den Meldetatbestand "Masern"
vaccineMYTDAntwortmöglichkeiten für die Angabe des Impfstoffs in Bezug auf den Meldetatbestand "Tuberkulose"
vaccineNEIDAntwortmöglichkeiten für die Angabe des Impfstoffs in Bezug auf den Meldetatbestand "Meningokokken, invasive Erkrankung"
vaccinePKVDAntwortmöglichkeiten für die Angabe des Impfstoffs in Bezug auf den Meldetatbestand "Pocken"
vaccinePOVDAntwortmöglichkeiten für die Angabe des Impfstoffs in Bezug auf den Meldetatbestand "Poliomyelitis"
vaccineRBVDAntwortmöglichkeiten für die Angabe des Impfstoffs in Bezug auf den Meldetatbestand "Tollwut"
vaccineRUVDAntwortmöglichkeiten für die Angabe des Impfstoffs in Bezug auf den Meldetatbestand "Röteln, postnatal"
vaccineSSPDAntwortmöglichkeiten für die Angabe des Impfstoffs in Bezug auf den Meldetatbestand "Subakute sklerosierende Panenzephalitis (SSPE)"
vaccineSTYDAntwortmöglichkeiten für die Angabe des Impfstoffs in Bezug auf den Meldetatbestand "Typhus"
vaccineSXXDAntwortmöglichkeiten für die Angabe des Impfstoffs in Bezug auf den Meldetatbestand "Paratyphus/Typhus, nicht differenziert"
vaccineTTVDAntwortmöglichkeiten für die Angabe des Impfstoffs in Bezug auf den Meldetatbestand "Tollwutexpositionsverdacht"
vaccineVCHDAntwortmöglichkeiten für die Angabe des Impfstoffs in Bezug auf den Meldetatbestand "Cholera"
vaccineVZWDAntwortmöglichkeiten für die Angabe des Impfstoffs in Bezug auf den Meldetatbestand "Windpocken"
vaccineVZZDAntwortmöglichkeiten für die Angabe des Impfstoffs in Bezug auf den Meldetatbestand "Herpes Zoster"
yesOrNoOrNoInformationAnwort Ja/Nein/nicht erhoben/nicht ermittelbar
legal-statusLegal Status
personal-income-sourcePersonal Income Source
pre-existing-conditionsPre-existing Conditions
official-languagePreferred Official Language
service-termination-reasonService Termination Reason
human-languageLanguage
bornInCanadaResponseBorn in Canada Response
employment-statusEmployment Status
highest-level-of-education-attainedHighest Level of Education Attained
sexual-orientationSexual Orientation
total-household-incomeTotal Household Income
versicherungsart-de-basisVersicherungsartDeBasisVS
no-colonoscopy-boston-bowel-preparation-scaleColonoscopy Report Boston Bowel Preparation Scale
no-colonoscopy-complicationColonoscopy Report Complications
no-colonoscopy-complication-consequenceColonoscopy Report Complication Consequences
no-colonoscopy-current-medicationColonoscopy Report Current Medication
no-colonoscopy-followupColonoscopy Report Follow Up
no-colonoscopy-laxativesColonoscopy Report Laxatives
no-colonoscopy-laxatives-split-doseColonoscopy Report Laxatives Split Dose
no-colonoscopy-medicationColonoscopy Report Medication
no-colonoscopy-medication-krgKRG Medication
no-colonoscopy-method-tissue-removal-biopsyColonoscopy Report Tissue Removal Method
no-colonoscopy-paris-polyp-classificationColonoscopy Report Colonoscopy Paris Polyp Classification
no-colonoscopy-procedure-reason-krgKRG Indication
no-colonoscopy-relevant-conditionsColonoscopy Report Relevant Conditions
no-colonoscopy-procedure-reason-gastronetColonoscopy Report Indication
HealthcareServiceSpecialtyFachspezialisierung (Werteliste)
PractitionerRolePersonenrolle (Werteliste)
birthsexBirth Sex
answerSetAddressUseAntwortenmöglichkeiten Adressnutzung
ValueSet-yes-no-unknown-not-applicableValueSet - Yes No Unknown NotApplicable
gambling-activities-in-last-yearGambling Activities In Last Year
religion-and-spiritual-affiliationReligionAndSpiritualAffiliation
israel-hmoIsraeli Health Management Organization (קופת חולים)
indigenousidentitycodeIndigenous Identity Code
genderidentityvaluecodeGender Identity Value Set
genderusedvaluecodeGender Used Value Set
recordedgenderRecorded Gender Value Set
sexassignedatbirthSex assigned at Birth
sexualorientationcodeSex Orientation Value Set
2.16.840.1.113883.2.4.3.11.60.40.2.7.3.2--20200901000000AlcoholGebruikStatusCodelijst
2.16.840.1.113883.2.4.3.11.60.40.2.8.3.2--20200901000000AlertNaamCodelijst
2.16.840.1.113883.2.4.3.11.60.40.2.8.2.2--20200901000000AllergieCategorieCodelijst
2.16.840.1.113883.2.4.3.11.60.40.2.15.1.3--20200901000000BestemmingCodelijst
2.16.840.1.113883.2.4.3.11.60.40.2.12.8.6--20200901000000ConditiesTijdensMetingCodelijst
2.16.840.1.113883.2.4.3.11.60.40.2.15.1.1--20200901000000ContactTypeCodelijst
2.16.840.1.113883.2.4.3.11.60.40.2.7.4.2--20200901000000DrugsGebruikStatusCodelijst
2.16.840.1.113883.2.4.3.11.60.40.2.7.4.1--20200901000000DrugsOfGeneesmiddelSoortCodelijst
2.16.840.1.113883.2.4.3.11.60.40.2.12.8.1--20200901000000GCS_EyesCodelijst
2.16.840.1.113883.2.4.3.11.60.40.2.12.8.2--20200901000000GCS_MotorCodelijst
2.16.840.1.113883.2.4.3.11.60.40.2.12.8.8--20200901000000GCS_MotorCodelijstBaby
2.16.840.1.113883.2.4.3.11.60.40.2.12.8.7--20200901000000GCS_MotorCodelijstKleuter
2.16.840.1.113883.2.4.3.11.60.40.2.12.8.3--20200901000000GCS_VerbalCodelijst
2.16.840.1.113883.2.4.3.11.60.40.2.12.8.5--20200901000000GCS_VerbalCodelijstBaby
2.16.840.1.113883.2.4.3.11.60.40.2.12.8.4--20200901000000GCS_VerbalCodelijstKleuter
2.16.840.1.113883.2.4.3.11.60.40.2.0.1.1--20200901000000GeslachtCodelijst
2.16.840.1.113883.2.4.3.11.60.40.2.17.1.8--20200901000000GeslachtCodelijst
2.16.840.1.113883.2.4.3.11.60.40.2.15.1.2--20200901000000HerkomstCodelijst
2.16.840.1.113883.2.4.3.11.60.40.2.7.5.1--20200901000000LevensovertuigingCodelijst
2.16.840.1.113883.2.4.3.11.60.40.2.20.4.1--20200901000000NaamgebruikCodelijst
2.16.840.1.113883.2.4.3.11.60.121.11.12--20200901000000ProductCodeCodelijsten
2.16.840.1.113883.2.4.3.11.60.40.2.10.1.1--20200901000000ProductTypeCodelijst
2.16.840.1.113883.2.4.3.11.60.40.2.3.1.1--20200901000000RelatieCodelijst
2.16.840.1.113883.2.4.3.11.60.40.2.19.3.1--20200901000000SoortAandoeningCodelijst
2.16.840.1.113883.2.4.3.11.60.40.2.7.2.3--20200901000000SoortTabakGebruikCodelijst
2.16.840.1.113883.2.4.3.11.60.40.2.5.2.1--20200901000000StomaTypeCodelijst
2.16.840.1.113883.2.4.3.11.60.40.2.8.2.5--20200901000000SymptoomCodelijst
2.16.840.1.113883.2.4.3.11.60.40.2.7.2.2--20200901000000TabakGebruikStatusCodelijst
2.16.840.1.113883.2.4.3.11.60.40.2.7.4.3--20200901000000ToedieningswegCodelijst
2.16.840.1.113883.2.4.3.11.60.40.2.5.1.4--20200901000000VerificatieStatusCodelijst
2.16.840.1.113883.2.4.3.11.60.40.2.12.19.4--20200901000000VisusMeetHulpmiddelCodelijst
2.16.840.1.113883.2.4.3.11.60.40.2.12.19.3--20200901000000VisusMetingKaartCodelijst
2.16.840.1.113883.2.4.3.11.60.40.2.12.19.2--20200901000000VisusMetingTypeCodelijst
2.16.840.1.113883.2.4.3.11.60.40.2.7.15.1--20200901000000WilsverklaringTypeCodelijst
2.16.840.1.113883.2.4.3.11.60.40.2.19.2.5--20200901000000WondRandCodelijst
2.16.840.1.113883.2.4.3.11.60.40.2.19.2.4--20200901000000WondSoortCodelijst
2.16.840.1.113883.2.4.3.11.60.40.2.7.8.1--20200901000000WoningTypeCodelijst
2.16.840.1.113883.2.4.3.11.60.40.2.4.16.2--20200901000000ZienHulpmiddelTypeCodelijst
2.16.840.1.113883.2.4.3.11.60.40.2.17.1.5--20200901000000ZorgverlenerRolCodelijst
SalutationAnrede
vs-orpha-predisposition-eu-pcspHereditary Predispositions (Orphacode)
vs-othUnkTxt-eu-pcspOther/Unknown/Text
vs-unknownOther-eu-pcspUnknown|Other
cyehr-vs-ehdsinullflavorCyprus EHR Value Set: eHDSI Null Flavor
cyehr-vs-drugormedicationtypeCyprus EHR Value Set: Drug Or Medication Type
cyehr-vs-drugusestatusCyprus EHR Value Set: Drug Use Status
cyehr-vs-exerciseCyprus EHR Value Set: Exercise
cyehr-vs-findingrelatedtosleepCyprus EHR Value Set: Finding Related To Sleep
cyehr-vs-respiratoryrhythmCyprus EHR Value Set: Respiratory Rhythm
cyehr-vs-tobaccotypeCyprus EHR Value Set: Tobacco Type
cyehr-vs-heartrhythmCyprus EHR Value Set: Heart Rhythm
fr-core-vs-marital-statusFR Core ValueSet Patient gender INS ValueSet
gender-identityGender Identity
v3-AskedButUnknownAskedButUnknown
v3-ClassNullFlavorClassNullFlavor
v3-NoInformationNoInformation
v3-NullFlavorNullFlavor
v3-OtherOther
v3-UnknownUnknown
2.16.840.1.114222.4.11.1006Type of Long Term Care Facility
2.16.840.1.114222.4.11.1010Microscopic Exam Culture Site (TB)
2.16.840.1.114222.4.11.1018Non Paint Lead Source
2.16.840.1.114222.4.11.1021Number Of Lesions (VZ)
2.16.840.1.114222.4.11.1022Occupation Risk Category (TB)
2.16.840.1.114222.4.11.1026Pregnancy Trimester
2.16.840.1.114222.4.11.1032Rash Distribution (VZ)
2.16.840.1.114222.4.11.1033Rash Location First Noted (VZ)
2.16.840.1.114222.4.11.1035Reason Therapy Stopped (TB)
2.16.840.1.114222.4.11.1048Strain Type (VZ)
2.16.840.1.114222.4.11.1050Batch Deactivation Reason
2.16.840.1.114222.4.11.1051Substance Treatment Refusal Reason
2.16.840.1.114222.4.11.1052Transmission Setting (NND)
2.16.840.1.114222.4.11.1056Vaccination Location (CRA)
2.16.840.1.114222.4.11.1058Vaccine Purchased With Funds
2.16.840.1.114222.4.11.1060Abnormal Chest X-ray Condition Status
2.16.840.1.114222.4.11.3015Ethnicity Group including Unknown
2.16.840.1.114222.4.11.3017Lab Test Result (PHLIP Flu)
2.16.840.1.114222.4.11.3024Blood Contact Frequency (Hepatitis)
2.16.840.1.114222.4.11.3025Case Confirmation Method
2.16.840.1.114222.4.11.3026Case Detection Method
2.16.840.1.114222.4.11.3027Case Transmission Mode
2.16.840.1.114222.4.11.3030Disease Acquired Jurisdiction
2.16.840.1.114222.4.11.3033Number Of Sex Partners (Hepatitis)
2.16.840.1.114222.4.11.3035Reason For Test (Hepatitis)
2.16.840.1.114222.4.11.3036Reporting Source Type
2.16.840.1.114222.4.11.3037Tattoo Obtained From (Hepatitis)
2.16.840.1.114222.4.11.3040Isolate Not Available EIP Test Reason
2.16.840.1.114222.4.11.3041Isolate Not Received Reason
2.16.840.1.114222.4.11.3042Isolate Not Sent To NARMS Reason
2.16.840.1.114222.4.11.3046Specimen Reshipment Reason
2.16.840.1.114222.4.11.3048Lab Test Interpretation
2.16.840.1.114222.4.11.3059Clinical Syndrome (Arbovirus)
2.16.840.1.114222.4.11.3061Public Private Lab
2.16.840.1.114222.4.11.3064Yes No Unknown No Answer
2.16.840.1.114222.4.11.3067Virus Variant Type (Animal Rabies)
2.16.840.1.114222.4.11.3068Animal Species (Animal Rabies)
2.16.840.1.114222.4.11.3069Yes No Unknown Not Done
2.16.840.1.114222.4.11.3070Botulism Food Source Type (FDD)
2.16.840.1.114222.4.11.3071Pregnancy Outcome (FDD)
2.16.840.1.114222.4.11.3072Animal Type (FDD)
2.16.840.1.114222.4.11.3073Botulinum Toxin Type (FDD)
2.16.840.1.114222.4.11.3074Case Traced to Carrier
2.16.840.1.114222.4.11.3075Cholera Risk Factor (FDD)
2.16.840.1.114222.4.11.3076Cholera Sequelae (FDD)
2.16.840.1.114222.4.11.3077Cholera Signs Symptoms (FDD)
2.16.840.1.114222.4.11.3078Cyclosporiasis Signs Symptoms (FDD)
2.16.840.1.114222.4.11.3081Fetal Neonatal Infection Type (FDD)
2.16.840.1.114222.4.11.3082Fetal Neonatal Specimen Type
2.16.840.1.114222.4.11.3083Food Cooking Method (FDD)
2.16.840.1.114222.4.11.3084Food Processing Method (FDD)
2.16.840.1.114222.4.11.3085Fresh Berries (FDD)
2.16.840.1.114222.4.11.3086Fresh Herbs (FDD)
2.16.840.1.114222.4.11.3087Fresh Produce (FDD)
2.16.840.1.114222.4.11.3088Information Source
2.16.840.1.114222.4.11.3090Lettuce Type (FDD)
2.16.840.1.114222.4.11.3091Maternal Infection (FDD)
2.16.840.1.114222.4.11.3092Meat Purchase Info (FDD)
2.16.840.1.114222.4.11.3093Non Pork Type (FDD)
2.16.840.1.114222.4.11.3094Other Related Cases
2.16.840.1.114222.4.11.3095Outbreak Type (FDD)
2.16.840.1.114222.4.11.3096Pork Type (FDD)
2.16.840.1.114222.4.11.3097Present Absent Unknown Not Examined
2.16.840.1.114222.4.11.3098Recreational Water (FDD)
2.16.840.1.114222.4.11.3099Seafood Purchase Info (FDD)
2.16.840.1.114222.4.11.3101Skin Exposure (FDD)
2.16.840.1.114222.4.11.3102Skin Exposure Activity (FDD)
2.16.840.1.114222.4.11.3103Suspected Food Consumed (FDD)
2.16.840.1.114222.4.11.3104Swimming Pool Type (FDD)
2.16.840.1.114222.4.11.3105Tap Water Source (FDD)
2.16.840.1.114222.4.11.3108Travel Purpose
2.16.840.1.114222.4.11.3109Travelers Health Info Source
2.16.840.1.114222.4.11.3110Trichinellosis Signs Symptoms (FDD)
2.16.840.1.114222.4.11.3111Typhoid Signs Symptoms (FDD)
2.16.840.1.114222.4.11.3112Underlying Conditions
2.16.840.1.114222.4.11.3113Water Salinity (FDD)
2.16.840.1.114222.4.11.3114Well Water Treatment (FDD)
2.16.840.1.114222.4.11.3115Wound History
2.16.840.1.114222.4.11.3117Body Site (FDD)
2.16.840.1.114222.4.11.3119Acute Convalescent IgG Difference (VPD)
2.16.840.1.114222.4.11.3120Antibiotic Received (Pertussis)
2.16.840.1.114222.4.11.3121Birth Attendees (VPD)
2.16.840.1.114222.4.11.3122Birth Location (VPD)
2.16.840.1.114222.4.11.3123Birth Outcome (VPD)
2.16.840.1.114222.4.11.3125Case Classification Exposure Source
2.16.840.1.114222.4.11.3126Genotype (Measles)
2.16.840.1.114222.4.11.3127Genotype (Rubella)
2.16.840.1.114222.4.11.3128Immunization Information Source (CRS)
2.16.840.1.114222.4.11.3129Injury Occurred Environment (VPD)
2.16.840.1.114222.4.11.3130Injury Type (VPD)
2.16.840.1.114222.4.11.3134No Case Reason (CRS)
2.16.840.1.114222.4.11.3137Prenatal Care Provider (Rubella)
2.16.840.1.114222.4.11.3138Relationship (VPD)
2.16.840.1.114222.4.11.3140Specimen Source (CRS)
2.16.840.1.114222.4.11.3141Specimen Source (VPD)
2.16.840.1.114222.4.11.3142Test Method EIA IgM
2.16.840.1.114222.4.11.3143Tetanus Type (VPD)
2.16.840.1.114222.4.11.3144Treatment Outcome Tetanus (VPD)
2.16.840.1.114222.4.11.3145Vaccine Doses Received (Pertussis)
2.16.840.1.114222.4.11.3146Vaccine Doses Received (Tetanus)
2.16.840.1.114222.4.11.3147Medication Received (VZ)
2.16.840.1.114222.4.11.3148PCR Specimen Source (VZ)
2.16.840.1.114222.4.11.3150IgM Test Type (VZ)
2.16.840.1.114222.4.11.3151IgG Test Type (VZ)
2.16.840.1.114222.4.11.3154Vaccines Administered (VZ)
2.16.840.1.114222.4.11.3159Reporting Lab Type
2.16.840.1.114222.4.11.3161Primary Reason For Evaluation (TB)
2.16.840.1.114222.4.11.3162Risk Factors (TB)
2.16.840.1.114222.4.11.3163Immigration Status
2.16.840.1.114222.4.11.3164Sputum Culture Conversion Not Documented Reason
2.16.840.1.114222.4.11.3166Cause of Death Related to TB
2.16.840.1.114222.4.11.3167Therapy Extended Reason (TB)
2.16.840.1.114222.4.11.3169Birth Country (TB)
2.16.840.1.114222.4.11.3200Birth Country
2.16.840.1.114222.4.11.3201Geographical location history
2.16.840.1.114222.4.11.3244Medication Treatment (Flu)
2.16.840.1.114222.4.11.3246Specimen (Flu)
2.16.840.1.114222.4.11.3254Employment Status (Flu)
2.16.840.1.114222.4.11.3259Age Group (Flu)
2.16.840.1.114222.4.11.3261Death Location (Flu)
2.16.840.1.114222.4.11.3264Sterile Specimen (Pediatric Flu)
2.16.840.1.114222.4.11.3265Positive Negative Unknown
2.16.840.1.114222.4.11.3266Microorganism (Pediatric Flu)
2.16.840.1.114222.4.11.3267Non-Sterile Specimen (Pediatric Flu)
2.16.840.1.114222.4.11.3268Acute Illness Complications (Pediatric Flu)
2.16.840.1.114222.4.11.3269Underlying Conditions (Pediatric Flu)
2.16.840.1.114222.4.11.3301Lab Test Interpretation (VPD)
2.16.840.1.114222.4.11.3302Lab Test Procedure (Measles)
2.16.840.1.114222.4.11.3303Specimen Source (Measles)
2.16.840.1.114222.4.11.3304Parotitis Laterality (Mumps)
2.16.840.1.114222.4.11.3305Type of Deafness (Mumps)
2.16.840.1.114222.4.11.3306Lab Test Procedure (Mumps)
2.16.840.1.114222.4.11.3307Specimen Source (Mumps)
2.16.840.1.114222.4.11.3308Complications (Malaria)
2.16.840.1.114222.4.11.3310Medication Missed (Malaria)
2.16.840.1.114222.4.11.3311Medication Prophylaxis (Malaria)
2.16.840.1.114222.4.11.3312Medication Treatment (Malaria)
2.16.840.1.114222.4.11.3313Species (Malaria)
2.16.840.1.114222.4.11.3314Specimen Type (Malaria)
2.16.840.1.114222.4.11.3315Travel Reason (Malaria)
2.16.840.1.114222.4.11.3316Antimicrobial Agent (IPD)
2.16.840.1.114222.4.11.3318Bacterial Infection Syndrome (IPD)
2.16.840.1.114222.4.11.3319Oxacillin Interpretation (IPD)
2.16.840.1.114222.4.11.3320Serotype Method (IPD)
2.16.840.1.114222.4.11.3321Sterile Specimen (IPD)
2.16.840.1.114222.4.11.3322Underlying Conditions (IPD)
2.16.840.1.114222.4.11.3323Birth Outcome (Rubella)
2.16.840.1.114222.4.11.3336Susceptibility Result (IPD)
2.16.840.1.114222.4.11.3402Age Unit (Syndromic Surveillance)
2.16.840.1.114222.4.11.3405Race Category including Unknown
2.16.840.1.114222.4.11.3406Disease Acquired Jurisdiction (NETSS)
2.16.840.1.114222.4.11.3407Case Class Status (NETSS)
2.16.840.1.114222.4.11.3408Age Unit (NETSS)
2.16.840.1.114222.4.11.3409Transmission Setting (NETSS)
2.16.840.1.114222.4.11.3410Vaccine Not Given Reasons (NETSS)
2.16.840.1.114222.4.11.3412Injury Occurred Environment (NETSS)
2.16.840.1.114222.4.11.3413Injury Type (NETSS)
2.16.840.1.114222.4.11.3414Birth Attendees (NETSS)
2.16.840.1.114222.4.11.3415Vaccines Administered (NETSS)
2.16.840.1.114222.4.11.3416Manufacturers Of Vaccines (NETSS)
2.16.840.1.114222.4.11.3417Contact Type Hepatitis A (NETSS)
2.16.840.1.114222.4.11.3418Sexual Preference (NETSS)
2.16.840.1.114222.4.11.3419Lab Test Result Lyme (NETSS)
2.16.840.1.114222.4.11.3420Microorganism (NETSS)
2.16.840.1.114222.4.11.3421Bacterial Infection Syndrome (NETSS)
2.16.840.1.114222.4.11.3422Associated Conditions (NETSS)
2.16.840.1.114222.4.11.3423Antibiotic Treatment (NETSS)
2.16.840.1.114222.4.11.3425Geographic Region (NETSS)
2.16.840.1.114222.4.11.3432Serogroup (NETSS)
2.16.840.1.114222.4.11.3435Serotype (NETSS)
2.16.840.1.114222.4.11.3598Wound Depth Tetanus (NETSS)
2.16.840.1.114222.4.11.3599Time Period Tetanus (NETSS)
2.16.840.1.114222.4.11.3600Stay Period Hepatitis (NETSS)
2.16.840.1.114222.4.11.4005Lab Result (Babesiosis)
2.16.840.1.114222.4.11.6001Certifier Types (NCHS)
2.16.840.1.114222.4.11.6003Pregnancy Status (NCHS)
2.16.840.1.114222.4.11.6004Contributory Tobacco Use (NCHS)
2.16.840.1.114222.4.11.6005Transportation Relationships (NCHS)
2.16.840.1.114222.4.11.6070Infections During Pregnancy - Live Birth (NCHS)
2.16.840.1.114222.4.11.7103VPD Laboratory Coded Observation
2.16.840.1.114222.4.11.7104VPD Specimen Type
2.16.840.1.114222.4.11.7111Birth Attendant Titles (NCHS)
2.16.840.1.114222.4.11.7112Fetal Death Time Points (NCHS)
2.16.840.1.114222.4.11.7113Fetal Presentations (NCHS)
2.16.840.1.114222.4.11.7124Birth or Delivery Occurred (NCHS)
2.16.840.1.114222.4.11.7135Infections During Pregnancy Fetal Death (NCHS)
2.16.840.1.114222.4.11.7166Binational Reporting Criteria (BIDS)
2.16.840.1.114222.4.11.7167Case Transmission Mode (BIDS)
2.16.840.1.114222.4.11.7170Specimen Site (BIDS)
2.16.840.1.114222.4.11.7171Salmonella Serogroup (BIDS)
2.16.840.1.114222.4.11.7174Campylobacter Nonculture Test Type (BIDS)
2.16.840.1.114222.4.11.7176STEC Nonculture Test Type (BIDS)
2.16.840.1.114222.4.11.7177E. coli Shiga Toxin Test Type (BIDS)
2.16.840.1.114222.4.11.7178E. coli Shiga Toxin (BIDS)
2.16.840.1.114222.4.11.7179Vibrio Culture Species (BIDS)
2.16.840.1.114222.4.11.7180Vibrio Serotype (BIDS)
2.16.840.1.114222.4.11.7181Vibrio Biotype (BIDS)
2.16.840.1.114222.4.11.7182Vibrio Cholera Toxin Test Type (BIDS)
2.16.840.1.114222.4.11.7188Travel Reason (Hepatitis A)
2.16.840.1.114222.4.11.7189Specimen Source (STD)
2.16.840.1.114222.4.11.7191Syphilis Neurologic Involvement (STD)
2.16.840.1.114222.4.11.7192HIV Status (STD)
2.16.840.1.114222.4.11.7193YNRD (CDC)
2.16.840.1.114222.4.11.7195Clinician Observed Lesions (STD)
2.16.840.1.114222.4.11.7199Detection Method (STD)
2.16.840.1.114222.4.11.7203Quantitative Syphilis Test Result (STD)
2.16.840.1.114222.4.11.7204Race Category including Refused
2.16.840.1.114222.4.11.7205Race Category including Null Flavor
2.16.840.1.114222.4.11.7206Lab Test Result Qualitative (NND)
2.16.840.1.114222.4.11.7212Certifier Titles (NCHS)
2.16.840.1.114222.4.11.7216Place of Death (NCHS)
2.16.840.1.114222.4.11.7217Lab Test Reactivity (NND)
2.16.840.1.114222.4.11.7218Syphilis Clinical Stage (CS)
2.16.840.1.114222.4.11.7219Syphilis Surveillance Stage (CS)
2.16.840.1.114222.4.11.7220Pregnancy Treatment Stage (NND)
2.16.840.1.114222.4.11.7221Syphilis Treatment Mother (CS)
2.16.840.1.114222.4.11.7223Birth Status (NND)
2.16.840.1.114222.4.11.7224Darkfield DFA Result (CS)
2.16.840.1.114222.4.11.7225Signs Symptoms (CS)
2.16.840.1.114222.4.11.7226X-Ray Result (CS)
2.16.840.1.114222.4.11.7227VDRL Test Result (NND)
2.16.840.1.114222.4.11.7228CSF WBC Protein Result (NND)
2.16.840.1.114222.4.11.7229Syphilis Treatment Infant (CS)
2.16.840.1.114222.4.11.7247Symptoms (EVD Triage)
2.16.840.1.114222.4.11.7249Exposure Risk (EVD)
2.16.840.1.114222.4.11.7265Duration Unit
2.16.840.1.114222.4.11.7269Reason for Missing Test (NND)
2.16.840.1.114222.4.11.7270Lab Test Result Interpretation (NND)
2.16.840.1.114222.4.11.7279Non-Treponemal Test Result (STD)
2.16.840.1.114222.4.11.7282Complications (Mumps)
2.16.840.1.114222.4.11.7283Signs and Symptoms (Mumps)
2.16.840.1.114222.4.11.7284Signs and Symptoms (Pertussis)
2.16.840.1.114222.4.11.7285Complications (Pertussis)
2.16.840.1.114222.4.11.7329Type of Testing at CDC (NND)
2.16.840.1.114222.4.11.7330Performing Laboratory Type (VPD)
2.16.840.1.114222.4.11.7331Vaccine Administered (MMR)
2.16.840.1.114222.4.11.7332Setting of Further Spread
2.16.840.1.114222.4.11.7333Timing of Maternal Treatment (NND)
2.16.840.1.114222.4.11.7334Lab Test Interpretation (Pertussis)
2.16.840.1.114222.4.11.7335Vaccine Administered (Pertussis)
2.16.840.1.114222.4.11.7359Point of Origin (NCHS)
2.16.840.1.114222.4.11.7361Disposition OPD (NCHS)
2.16.840.1.114222.4.11.7362Follow-up Attempt Outcome (NCHS)
2.16.840.1.114222.4.11.7365Priority (Type) of Admission or Visit (NCHS)
2.16.840.1.114222.4.11.7369Present on Admission (NCHS)
2.16.840.1.114222.4.11.7372Time Units (NCHS)
2.16.840.1.114222.4.11.7373Race (NCHS)
2.16.840.1.114222.4.11.7374Place of Injury (NCHS)
2.16.840.1.114222.4.11.7375Ethnicity Group (NCHS)
2.16.840.1.114222.4.11.7376Ethnicity Detail (NCHS)
2.16.840.1.114222.4.11.7379Methods of Disposition (NCHS)
2.16.840.1.114222.4.11.7385Decedent Education Level (NCHS)
2.16.840.1.114222.4.11.7422Fetal Death Cause or Condition (NCHS)
2.16.840.1.114222.4.11.7437Disposition ED (NCHS)
2.16.840.1.114222.4.11.7441Neurological Manifestation (STD)
2.16.840.1.114222.4.11.7446States Territories Provinces (NCHS)
2.16.840.1.114222.4.11.7448Vaccine Type (NND)
2.16.840.1.114222.4.11.7450Vaccine Event Information Source (NND)
2.16.840.1.114222.4.11.7451Type of Testing at CDC (VZ)
2.16.840.1.114222.4.11.7452Age Unit (NND)
2.16.840.1.114222.4.11.7453Body Region(s) of Rash
2.16.840.1.114222.4.11.7454Character of Lesions
2.16.840.1.114222.4.11.7473Diagnostic Lab Test Findings (NND)
2.16.840.1.114222.4.11.7474Type of Complication (VZ)
2.16.840.1.114222.4.11.7478Serotype (Dengue)
2.16.840.1.114222.4.11.7486Yes No Not Applicable (NCHS)
2.16.840.1.114222.4.11.7487Reason for Hospitalization (VZ)
2.16.840.1.114222.4.11.7490Clinical Syndrome - Secondary (Arbovirus)
2.16.840.1.114222.4.11.7495Serotype (Arbovirus)
2.16.840.1.114222.4.11.7537Duration Unit (1)
2.16.840.1.114222.4.11.7538Type of Complication (Babesiosis)
2.16.840.1.114222.4.11.7539Medication Treatment (Babesiosis)
2.16.840.1.114222.4.11.7540Blood Product
2.16.840.1.114222.4.11.7541Clinical Manifestations (Babesiosis)
2.16.840.1.114222.4.11.7544Outdoor Activities
2.16.840.1.114222.4.11.7551Test Result Coded Qualitative
2.16.840.1.114222.4.11.7553Specimen Type AST (STD)
2.16.840.1.114222.4.11.7554Specimen Collection Site AST (STD)
2.16.840.1.114222.4.11.756Gender Identity
2.16.840.1.114222.4.11.7563Sexual Orientation
2.16.840.1.114222.4.11.7582Vital Records Education Level (NCHS)
2.16.840.1.114222.4.11.7585Fetal Remains Disposition Method (NCHS)
2.16.840.1.114222.4.11.7607Type of Testing at CDC
2.16.840.1.114222.4.11.7608Type Of Complication (CRS)
2.16.840.1.114222.4.11.7609Sexual Orientation (STD)
2.16.840.1.114222.4.11.7610Gender Identity (STD)
2.16.840.1.114222.4.11.7611Clinical Manifestations (STD)
2.16.840.1.114222.4.11.7612Late Clinical Manifestation (STD)
2.16.840.1.114222.4.11.7615Pre-Pregnancy SerologicalTestInterp (CRS)
2.16.840.1.114222.4.11.7616Specimen From Mother Or Infant (CRS)
2.16.840.1.114222.4.11.7617Organism (FDD)
2.16.840.1.114222.4.11.7618Yes No Unknown Refused (NND)
2.16.840.1.114222.4.11.7619Antibiotics (FDD)
2.16.840.1.114222.4.11.7620Antacids (FDD)
2.16.840.1.114222.4.11.7621Signs and Symptoms (FDD)
2.16.840.1.114222.4.11.7623Test Method (FDD)
2.16.840.1.114222.4.11.7625Test Type (FDD)
2.16.840.1.114222.4.11.7626Test Result (FDD)
2.16.840.1.114222.4.11.7627Specimen Collection Source (FDD)
2.16.840.1.114222.4.11.7628Yes No Unknown Maybe (FDD)
2.16.840.1.114222.4.11.7629Yes No Don't Know Maybe (FDD)
2.16.840.1.114222.4.11.7630Drinking Water (FDD)
2.16.840.1.114222.4.11.7631Recreational H2O Treatment (FDD)
2.16.840.1.114222.4.11.7632Raw Unpasteurized Products (FDD)
2.16.840.1.114222.4.11.7633Day Care Setting (FDD)
2.16.840.1.114222.4.11.7634Sexual Contact (FDD)
2.16.840.1.114222.4.11.7635Medication Administered (FDD)
2.16.840.1.114222.4.11.7636Medical History (FDD)
2.16.840.1.114222.4.11.7637Seafood Preparation (FDD)
2.16.840.1.114222.4.11.7638Seafood Source (FDD)
2.16.840.1.114222.4.11.7639Shellfish Distributed (FDD)
2.16.840.1.114222.4.11.7640Improper Handling Storage (FDD)
2.16.840.1.114222.4.11.7644Vibrio Cholera Serotype (FDD)
2.16.840.1.114222.4.11.7645Vibrio Cholera Biotype (FDD)
2.16.840.1.114222.4.11.7649Signs and Symptoms (Rubella)
2.16.840.1.114222.4.11.7650Type Of Complication (Rubella)
2.16.840.1.114222.4.11.7651Previous Case Diagnosed By (Rubella)
2.16.840.1.114222.4.11.7653Specimen Type (CRS)
2.16.840.1.114222.4.11.7655PCR Specimen Source (CRS)
2.16.840.1.114222.4.11.7656Specimen Source (Rubella)
2.16.840.1.114222.4.11.7657Specimen Type (Rubella)
2.16.840.1.114222.4.11.7659Type of Testing at CDC(Rubella)
2.16.840.1.114222.4.11.7660Type of Complication (Measles)
2.16.840.1.114222.4.11.7662Signs and Symptoms (Measles)
2.16.840.1.114222.4.11.7666Signs and Symptoms (Trich)
2.16.840.1.114222.4.11.7668Meat Consumed Type (Trich)
2.16.840.1.114222.4.11.7669Food Processing Method (Trich)
2.16.840.1.114222.4.11.7670Meat Purchase Info (Trich)
2.16.840.1.114222.4.11.7671Food Cooking Method (Trich)
2.16.840.1.114222.4.11.7672Performing Lab Type (Trich)
2.16.840.1.114222.4.11.7674Lab Test Interpretation (Trich)
2.16.840.1.114222.4.11.7675Specimen type (Trich)
2.16.840.1.114222.4.11.7676Strain Type (Trich)
2.16.840.1.114222.4.11.7678Discharge Location (RIBD)
2.16.840.1.114222.4.11.7679Pregnancy Status (RIBD)
2.16.840.1.114222.4.11.7680Fetal Outcome (RIBD)
2.16.840.1.114222.4.11.7681Underlying Condition (RIBD)
2.16.840.1.114222.4.11.7682Smoking Status (RIBD)
2.16.840.1.114222.4.11.7683Substance Abuse (RIBD)
2.16.840.1.114222.4.11.7684Mode of Delivery (RIBD)
2.16.840.1.114222.4.11.7686Microorganism (RIBD)
2.16.840.1.114222.4.11.7687Performing Lab Type (RIBD)
2.16.840.1.114222.4.11.7688Vaccine Type (RIBD)
2.16.840.1.114222.4.11.7689Vaccination Information Source (RIBD)
2.16.840.1.114222.4.11.7691GAS Risk Factor Interval (RIBD)
2.16.840.1.114222.4.11.7693Antibiotic Received (RIBD)
2.16.840.1.114222.4.11.7695Antibiotic Reason (RIBD)
2.16.840.1.114222.4.11.7696Detection Method (RIBD)
2.16.840.1.114222.4.11.7697Birth Location (RIBD)
2.16.840.1.114222.4.11.7698Gestational Age Determination (RIBD)
2.16.840.1.114222.4.11.7699Susceptibility Data NA (RIBD)
2.16.840.1.114222.4.11.7700AR Agent (RIBD)
2.16.840.1.114222.4.11.7702ATI Method (RIBD)
2.16.840.1.114222.4.11.7704Susceptibility Interpretation (RIBD)
2.16.840.1.114222.4.11.7706Sequelae (RIBD)
2.16.840.1.114222.4.11.7709Delivery Type (RIBD)
2.16.840.1.114222.4.11.7710Medication Pre-Treatment (RIBD)
2.16.840.1.114222.4.11.7711Contact Type (RIBD)
2.16.840.1.114222.4.11.7712School Year (RIBD)
2.16.840.1.114222.4.11.7713College Living Situation (RIBD)
2.16.840.1.114222.4.11.7715Legionella Exposure (RIBD)
2.16.840.1.114222.4.11.7716Definitely Possibly No (RIBD)
2.16.840.1.114222.4.11.7717Legionella Exposure Setting (RIBD)
2.16.840.1.114222.4.11.7718Healthcare Exposure Type (RIBD)
2.16.840.1.114222.4.11.7719Facility Type (RIBD)
2.16.840.1.114222.4.11.7720Water Source (RIBD)
2.16.840.1.114222.4.11.7721Cruise Line (RIBD)
2.16.840.1.114222.4.11.7722Titer Test Type (RIBD)
2.16.840.1.114222.4.11.7723Signs and Symptoms (RIBD)
2.16.840.1.114222.4.11.7724Personal Protective Equipment (RIBD)
2.16.840.1.114222.4.11.7725Respiratory Protective Equipment (RIBD)
2.16.840.1.114222.4.11.7726Glove Material (RIBD)
2.16.840.1.114222.4.11.7727Titer Test Method (RIBD)
2.16.840.1.114222.4.11.7728Bird Type (RIBD)
2.16.840.1.114222.4.11.7729Establishment Type (RIBD)
2.16.840.1.114222.4.11.7730Residence Location (RIBD)
2.16.840.1.114222.4.11.7731Insurance Type (RIBD)
2.16.840.1.114222.4.11.7732Infection Type (RIBD)
2.16.840.1.114222.4.11.7733Lab Test Method (RIBD)
2.16.840.1.114222.4.11.7734Lab Test Interpretation (RIBD)
2.16.840.1.114222.4.11.7735SPN/IPD Serotype (RIBD)
2.16.840.1.114222.4.11.7736Serotype Method (RIBD)
2.16.840.1.114222.4.11.7737Legionellosis Serogroup (RIBD)
2.16.840.1.114222.4.11.7740Colony Count Magnitude
2.16.840.1.114222.4.11.7744Lab Test Interpretation (TB)
2.16.840.1.114222.4.11.7745Type of Radiology Study
2.16.840.1.114222.4.11.7746Result of Radiology Study (TB)
2.16.840.1.114222.4.11.7747Diabetes Status
2.16.840.1.114222.4.11.7748Epidemiological Risk Factors (TB)
2.16.840.1.114222.4.11.7751Type of Link (TB)
2.16.840.1.114222.4.11.7755LTBI Drug Regimen (TB)
2.16.840.1.114222.4.11.7756Reason LTBI Not Started (TB)
2.16.840.1.114222.4.11.7757Reason LTBI Treatment Stopped (TB)
2.16.840.1.114222.4.11.7759Medication (TB)
2.16.840.1.114222.4.11.7761Susceptibility Test Interpretation (TB)
2.16.840.1.114222.4.11.7762Susceptibility Test Method (TB)
2.16.840.1.114222.4.11.7763Gene Name (TB)
2.16.840.1.114222.4.11.7764Molecular Test Results (TB)
2.16.840.1.114222.4.11.7765Molecular Indel (TB)
2.16.840.1.114222.4.11.7766Molecular Test Methods (TB)
2.16.840.1.114222.4.11.7767Reason Not Treated with RIPE (TB)
2.16.840.1.114222.4.11.7769Final Treatment Outcome (TB)
2.16.840.1.114222.4.11.7772Side Effect of Treatment (TB)
2.16.840.1.114222.4.11.7773Serogroup Method (RIBD)
2.16.840.1.114222.4.11.7774Specimen Type (RIBD)
2.16.840.1.114222.4.11.7778Specimen Site (FDD)
2.16.840.1.114222.4.11.7779Condition Status (FDD)
2.16.840.1.114222.4.11.7785Extended Race Group (Listeria)
2.16.840.1.114222.4.11.7787Food Allergy (Listeria)
2.16.840.1.114222.4.11.7789Fruit (Listeria)
2.16.840.1.114222.4.11.7790Heated Food (Listeria)
2.16.840.1.114222.4.11.7791Hispanic Ethnic Group (Listeria)
2.16.840.1.114222.4.11.7792Illness (Listeria)
2.16.840.1.114222.4.11.7793Likely Contact (Listeria)
2.16.840.1.114222.4.11.7794LikelyAte (Listeria)
2.16.840.1.114222.4.11.7795Medical History (Listeria)
2.16.840.1.114222.4.11.7796Patient Type (Listeria)
2.16.840.1.114222.4.11.7797Birth Location (Listeria)
2.16.840.1.114222.4.11.7798Pregnancy Outcome (Listeria)
2.16.840.1.114222.4.11.7799Reason Not Interviewed (Listeria)
2.16.840.1.114222.4.11.7800Respondent (Listeria)
2.16.840.1.114222.4.11.7801Signs and Symptoms (Listeria)
2.16.840.1.114222.4.11.7802Specimen Type (Listeria)
2.16.840.1.114222.4.11.7803Yes No Unknown Refused (Listeria)
2.16.840.1.114222.4.11.7804Patient Outcome (Listeria)
2.16.840.1.114222.4.11.7806Assisted Living Exposure Type (RIBD)
2.16.840.1.114222.4.11.7808N. meningitidis Serogroup (RIBD)
2.16.840.1.114222.4.11.7809H. influenzae Serotype (RIBD)
2.16.840.1.114222.4.11.7812Case Type (CP-CRE)
2.16.840.1.114222.4.11.7813Specimen Source (CP-CRE)
2.16.840.1.114222.4.11.7823Lab Test Interpretation (Legionellosis)
2.16.840.1.114222.4.11.7825Gene Name (CP-CRE)
2.16.840.1.114222.4.11.7826Specimen Source Site (VPD)
2.16.840.1.114222.4.11.7832Clinical Manifestation (TBRD)
2.16.840.1.114222.4.11.7833Complications (TBRD)
2.16.840.1.114222.4.11.7834Medication Received (TBRD)
2.16.840.1.114222.4.11.7836Organism (TBRD)
2.16.840.1.114222.4.11.7837Coinfection Type (TBRD)
2.16.840.1.114222.4.11.7838Specimen Type (TBRD)
2.16.840.1.114222.4.11.7839Medication Received (Lyme)
2.16.840.1.114222.4.11.7840Clinical Manifestations (Lyme)
2.16.840.1.114222.4.11.7841Specimen Type (Lyme)
2.16.840.1.114222.4.11.7843Organism (Lyme)
2.16.840.1.114222.4.11.7845Serotype Master (RIBD)
2.16.840.1.114222.4.11.7846Lab Test Interpretation Master (RIBD)
2.16.840.1.114222.4.11.7848Exposure Setting Master (RIBD)
2.16.840.1.114222.4.11.7849Usual Occupation and Industry (TB)
2.16.840.1.114222.4.11.7850Organism (CP-CRE)
2.16.840.1.114222.4.11.7851Contact Type (FDD)
2.16.840.1.114222.4.11.7852Geographic Location
2.16.840.1.114222.4.11.7861Death Reporting Decedent and Certificate Identifier Type (HL70203) (NCHS)
2.16.840.1.114222.4.11.7862Test Result (CP-CRE)
2.16.840.1.114222.4.11.7864Specimen Source (C. auris)
2.16.840.1.114222.4.11.7866Lab Test Method (MDRO)
2.16.840.1.114222.4.11.7868Type of Long Term Care Facility (C. auris)
2.16.840.1.114222.4.11.7869Specimen Collection Setting Type (C. auris)
2.16.840.1.114222.4.11.7870Type of Co-infection (C. auris)
2.16.840.1.114222.4.11.7874Poison Control Center Record (CO)
2.16.840.1.114222.4.11.7875Workers Compensation Record (CO)
2.16.840.1.114222.4.11.7876Intent of Exposure (CO)
2.16.840.1.114222.4.11.7877Extreme Weather Type (CO)
2.16.840.1.114222.4.11.7878Exposure Source (CO)
2.16.840.1.114222.4.11.7879Treatment Type (CO)
2.16.840.1.114222.4.11.7880Education (CO)
2.16.840.1.114222.4.11.7881Generator Location (CO)
2.16.840.1.114222.4.11.7882Generator Distance (CO)
2.16.840.1.114222.4.11.7883Person/Organization Taking CO Reading (CO)
2.16.840.1.114222.4.11.7884Exposure Site Category (CO)
2.16.840.1.114222.4.11.7885Public Site of Exposure (CO)
2.16.840.1.114222.4.11.7886Treatment Location (CO)
2.16.840.1.114222.4.11.7887Underlying Conditions (CO)
2.16.840.1.114222.4.11.7888Signs and Symptoms (CO)
2.16.840.1.114222.4.11.7889ICD Codes List (CO)
2.16.840.1.114222.4.11.7890Treatment Site (CO)
2.16.840.1.114222.4.11.7891Data Reporting Source (CO)
2.16.840.1.114222.4.11.7896Residential Site of Exposure (CO)
2.16.840.1.114222.4.11.7907Ethnicity (ARLN)
2.16.840.1.114222.4.11.7908Gender (ARLN)
2.16.840.1.114222.4.11.7914Acinetobacter culture result (ARLN)
2.16.840.1.114222.4.11.7921Specimen type (ARLN)
2.16.840.1.114222.4.11.7922Microorganism (ARLN)
2.16.840.1.114222.4.11.7923Medication Treatment (STD)
2.16.840.1.114222.4.11.7925Type of Complication (STD)
2.16.840.1.114222.4.11.7926Number of Cigarettes Smoked per Day (CO)
2.16.840.1.114222.4.11.7927Dose Unit (STD)
2.16.840.1.114222.4.11.7928Lab Test Result Qualitative (Syphilis)
2.16.840.1.114222.4.11.7929Medication Route (STD)
2.16.840.1.114222.4.11.7930Route of Administration (STD)
2.16.840.1.114222.4.11.7931Medication Frequency Unit (STD)
2.16.840.1.114222.4.11.7932Duration Units (STD)
2.16.840.1.114222.4.11.7934Microorganism (STD)
2.16.840.1.114222.4.11.7936Contact Type (COVID-19)
2.16.840.1.114222.4.11.7938Detection Method (COVID-19)
2.16.840.1.114222.4.11.7939Residence Type (COVID-19)
2.16.840.1.114222.4.11.7940Healthcare Occupation (COVID-19)
2.16.840.1.114222.4.11.7941Job Setting (COVID-19)
2.16.840.1.114222.4.11.7942Exposure Setting (COVID-19)
2.16.840.1.114222.4.11.7943Data Reporting Source (COVID-19)
2.16.840.1.114222.4.11.7944Signs and Symptoms (COVID-19)
2.16.840.1.114222.4.11.7945Clinical Finding (COVID-19)
2.16.840.1.114222.4.11.7946Animal Type (COVID-19)
2.16.840.1.114222.4.11.7947Risk Factor (COVID-19)
2.16.840.1.114222.4.11.7949Treatment Type (COVID-19)
2.16.840.1.114222.4.11.7950Yes No Unknown NA (NND)
2.16.840.1.114222.4.11.7951Reason for Test (COVID-19)
2.16.840.1.114222.4.11.7952Tribe Name (NND)
2.16.840.1.114222.4.11.7953Critical Infrastructure Sector (NND)
2.16.840.1.114222.4.11.7954Medication Administered (Hansen)
2.16.840.1.114222.4.11.7956Type of Leprosy (Hansen)
2.16.840.1.114222.4.11.7957Relationship (Hansen)
2.16.840.1.114222.4.11.7958Hospital Procedure (Leptospirosis)
2.16.840.1.114222.4.11.7959Underlying Condition(s) (Leptospirosis)
2.16.840.1.114222.4.11.7960Disease Outcome Type (Leptospirosis)
2.16.840.1.114222.4.11.7961Medication (Leptospirosis)
2.16.840.1.114222.4.11.7962Contact Type (Brucellosis)
2.16.840.1.114222.4.11.7963Medication Administered (Anthrax)
2.16.840.1.114222.4.11.7965Sick Animal Type (Leptospirosis)
2.16.840.1.114222.4.11.7966Rodent Type (Leptospirosis)
2.16.840.1.114222.4.11.7967Animal Type (Leptospirosis)
2.16.840.1.114222.4.11.7968Clinical Manifestations (Leptospirosis)
2.16.840.1.114222.4.11.7969Specimen Type (Brucellosis)
2.16.840.1.114222.4.11.7970Disease Stage (Brucellosis)
2.16.840.1.114222.4.11.7971Animal Type (Brucellosis)
2.16.840.1.114222.4.11.7972Medication (Brucellosis)
2.16.840.1.114222.4.11.7973Diagnostic Test Finding (Anthrax)
2.16.840.1.114222.4.11.7974Specimen Type (Leptospirosis)
2.16.840.1.114222.4.11.7975Specimen Source Site (Leptospirosis)
2.16.840.1.114222.4.11.7976Test Titer Type (Brucellosis)
2.16.840.1.114222.4.11.7977Brucella Exposure (Brucellosis)
2.16.840.1.114222.4.11.7978Exposure Risk (Brucellosis)
2.16.840.1.114222.4.11.7979Previous Treatment Duration (Hansen)
2.16.840.1.114222.4.11.7980Patient Case Status (Hansen)
2.16.840.1.114222.4.11.7981Animal Ownership (Brucellosis)
2.16.840.1.114222.4.11.7982Vaccine Exposure (Brucellosis)
2.16.840.1.114222.4.11.7984Hospital Procedure (Anthrax)
2.16.840.1.114222.4.11.7985Actual Route of Administration (Anthrax)
2.16.840.1.114222.4.11.7986Performing Lab Type (Anthrax)
2.16.840.1.114222.4.11.7987Country of Product Acquisition (Brucellosis)
2.16.840.1.114222.4.11.7988Location Type (Leptospirosis)
2.16.840.1.114222.4.11.7989Clinical Outcome (Anthrax)
2.16.840.1.114222.4.11.7990Specimen Type (Anthrax)
2.16.840.1.114222.4.11.7991Procedure Type (Anthrax)
2.16.840.1.114222.4.11.7992Public TransportationType (Anthrax)
2.16.840.1.114222.4.11.7994Exposure Type (Leptospirosis)
2.16.840.1.114222.4.11.7995Diet Type (Anthrax)
2.16.840.1.114222.4.11.7996Post-exposure or Treatment (NND)
2.16.840.1.114222.4.11.7997Treatment Type (Anthrax)
2.16.840.1.114222.4.11.7999Animal Type (Anthrax)
2.16.840.1.114222.4.11.8000Test Results Anthrax
2.16.840.1.114222.4.11.8002Reason Medication Not Completed (BSP)
2.16.840.1.114222.4.11.8003Smoking Status (Anthrax)
2.16.840.1.114222.4.11.8004Test Results (Brucellosis)
2.16.840.1.114222.4.11.8005Antimicrobials (Anthrax)
2.16.840.1.114222.4.11.8006Contact Type (Anthrax)
2.16.840.1.114222.4.11.8007Clinical Manifestations (Brucellosis)
2.16.840.1.114222.4.11.8008Clinical Manifestations (Anthrax)
2.16.840.1.114222.4.11.8009Exposure Location (Brucellosis)
2.16.840.1.114222.4.11.8010Organism Name (Brucellosis)
2.16.840.1.114222.4.11.8011Activity Type (Leptospirosis)
2.16.840.1.114222.4.11.8012Activity Type (Brucellosis)
2.16.840.1.114222.4.11.8013Exposure Source (Anthrax)
2.16.840.1.114222.4.11.8014Activity Type Anthrax
2.16.840.1.114222.4.11.8015Food Product Consumed (Brucellosis)
2.16.840.1.114222.4.11.8016Fresh Water or Mud Type (Leptospirosis)
2.16.840.1.114222.4.11.8017Exposure Source (Brucellosis)
2.16.840.1.114222.4.11.8021Total Doses of Vaccine (Anthrax)
2.16.840.1.114222.4.11.8024Medication Completed (Brucellosis)
2.16.840.1.114222.4.11.8029Division Vital Statistics (County)
2.16.840.1.114222.4.11.8030Lab Test (Hansen)
2.16.840.1.114222.4.11.8033Frequency Duration Unit (Hansen)
2.16.840.1.114222.4.11.8036Antibiotic Dose Units (Brucellosis)
2.16.840.1.114222.4.11.8037Test Type (Brucellosis)
2.16.840.1.114222.4.11.8038Specimen Source Site (Brucellosis)
2.16.840.1.114222.4.11.8039Test Results (Leptospirosis)
2.16.840.1.114222.4.11.8040Pregnancy Outcome (Leptospirosis)
2.16.840.1.114222.4.11.8041Lab Test Type (Leptospirosis)
2.16.840.1.114222.4.11.8042Test Result (Hepatitis A)
2.16.840.1.114222.4.11.8043HBeAg Test Result (Hepatitis B Perinatal)
2.16.840.1.114222.4.11.8044Infant Nucleic Acid Test Result (Hepatitis C)
2.16.840.1.114222.4.11.8045Infant HCV Antigen Test Result (Hepatitis C)
2.16.840.1.114222.4.11.8046Mother Nucleic Acid Test Result (Perinatal Hep)
2.16.840.1.114222.4.11.8048Common-Source Outbreak (Hepatitis B)
2.16.840.1.114222.4.11.8049Common-Source Outbreak (Hepatitis C)
2.16.840.1.114222.4.11.8051Patient Epidemiological Risk Factors (Hepatitis A)
2.16.840.1.114222.4.11.8052Patient Epidemiological Risk Factors (Hepatitis B)
2.16.840.1.114222.4.11.8053Patient Epidemiological Risk Factors (Hepatitis C)
2.16.840.1.114222.4.11.8054Alanine aminotransferase (ALT) Result (Hepatitis)
2.16.840.1.114222.4.11.8055Source of Laboratory Test (Hepatitis)
2.16.840.1.114222.4.11.8056HBsAg Test Result (Hepatitis B Perinatal)
2.16.840.1.114222.4.11.8057Infant Anti-HCVTest Result (Hepatitis C Perinatal)
2.16.840.1.114222.4.11.8060Test Result (Hepatitis)
2.16.840.1.114222.4.11.8061HBV DNA Test Result (Hepatitis B Perinatal)
2.16.840.1.114222.4.11.8062Gender Identity (USCDI)
2.16.840.1.114222.4.11.8063Sexual Orientation (USCDI)
2.16.840.1.114222.4.11.8064Travel Purpose (CDC)
2.16.840.1.114222.4.11.828Country
2.16.840.1.114222.4.11.829County
2.16.840.1.114222.4.11.831Language
2.16.840.1.114222.4.11.875Null Flavor (HL7 V3)
2.16.840.1.114222.4.11.878Age unit
2.16.840.1.114222.4.11.888Yes No Unknown (YNU)
2.16.840.1.114222.4.11.921Emergency Department Acuity
2.16.840.1.114222.4.11.929Positive Negative Unknown Not Done
2.16.840.1.114222.4.11.930Chest XRay Result
2.16.840.1.114222.4.11.931Vaccine Not Given Reason
2.16.840.1.114222.4.11.941Susceptibility Result
2.16.840.1.114222.4.11.950Passed Failed Unknown
2.16.840.1.114222.4.11.957Abnormal Chest X-Ray Finding (TB)
2.16.840.1.114222.4.11.959Additional Site of Disease (TB)
2.16.840.1.114222.4.11.968Case Classification Status
2.16.840.1.114222.4.11.970Case Investigation Status
2.16.840.1.114222.4.11.979Type of Correctional Facility
2.16.840.1.114222.4.11.980Diagnosed by (VZ)
2.16.840.1.114222.4.11.981Diagnosed Pneumonia By (VZ)
2.16.840.1.114222.4.11.982Directly Observed Therapy (TB)
2.16.840.1.114222.4.11.983Sites of Directly Observed Therapy (TB)
2.16.840.1.114222.4.11.985Employment Status
2.16.840.1.114222.4.11.992Epilinked Case Type (VZ)
2.16.840.1.114222.4.11.994General Condition Status
2.16.840.1.114222.4.11.995Health Care Practice Type (TB)
2.16.840.1.114222.4.11.997HIV Diagnosis Based On
2.16.840.1.114222.4.11.998HIV Status
2.16.840.1.114222.4.3.20Specimen Source Site (Anthrax)
omb-race-categoryOMB Race Categories
fips-county-coCO FIPS Counties
birthsexBirth Sex
detailed-ethnicityDetailed ethnicity
detailed-raceDetailed Race
encounter-special-courtesySpecial courtesy
2.16.840.1.113762.1.4.1021.32Gender Identity
omb-ethnicity-categoryOMB Ethnicity Categories
2.16.840.1.113883.2.4.3.11.60.20.77.11.9--20160407000000Aanvullende gebruiksinstructie
2.16.840.1.113883.2.4.3.11.60.20.77.11.57--20241101000000Financiële Indicatiecode
2.16.840.1.113883.2.4.3.11.60.20.77.11.47--20240131165054MedicatieToedieningRedenVanAfwijkenCodelijst
2.16.840.1.113883.2.4.3.11.60.20.77.11.53--20220323181942PrikPlakLocatieCodeLijst
2.16.840.1.113883.2.4.3.11.60.20.77.11.42--20221114132525RedenWijzigen-StakenCodelijst
2.16.840.1.113883.2.4.3.11.60.20.77.11.54--20221114181621RedenWijzigen-StakenWDSCodelijst
2.16.840.1.113883.2.4.3.11.60.20.77.11.43--20221115122002RedenWijzigen-StoppenGebruikCodelijst
2.16.840.1.113883.2.4.3.11.60.20.77.11.49--20221115120643Toedieningsafspraak-RedenWijzigen-StakenCodelijst
2.16.840.1.113883.2.4.3.11.60.40.2.9.12.4--20200901000000ZonodigCriteriumCodelijst
be-vs-vaccination-administration-routeBeVSVaccineAdministrationRoute
be-civilstateBeCivilstate
be-vs-vaccination-administration-routeVaccine Administration Route
eHDSIExceptionalValueeHDSI Exceptional Value
stationstypStationstyp
birthsexBirth Sex
AdministrationDeviceAdministrationDevice
ConditionsDuringMeasurementConditionsDuringMeasurement
DeviatingBreathingPatternDeviatingBreathingPattern
EstimatingMethodEstimatingMethod
FamilyCompositionFamilyComposition
FamilyCompositionChildFamilyCompositionChild
FeedingTubeTypeFeedingTubeType
InfusionCatheterTypeInfusionCatheterType
LifeStanceLifeStance
LineStatusLineStatus
StomaTypeStomaType
TypeOfDisorderTypeOfDisorder
UrineCatheterTypeUrineCatheterType
VisualAcuityMeasurementChartVisualAcuityMeasurementChart
VisualAcuityMeasurementDeviceVisualAcuityMeasurementDevice
VisualAcuityTypeVisualAcuityType
WoundEdgeWoundEdge
WoundTypeWoundType
OutbreakCategoryVSAusbruchskategorie-Werteliste
OutbreakEnvironmentSettingVSInfektionsumfeld
OutbreakInfectionRouteVSInfektionsweg
YesNoNullFlavorJa, Nein, Nicht ermittelbar, Nicht erhoben Antworten
NHSDigital-VaccineCodeNHS Digital Vaccine Code
uds-plus-insurance-codesUds Plus Insurance Codes
2.16.840.1.113883.2.4.3.11.60.26.11.7--20211028090253CategorieCodelijst
2.16.840.1.113883.2.4.3.11.60.26.11.41--20240910090504StartRedenCodelijst
2.16.840.1.113883.2.4.3.11.60.26.11.40--20240909075522StopRedenCodelijst
2.16.840.1.113883.2.4.3.11.60.26.11.14--20231120120019WijzeVanVaststellenCodelijst
PatientComorbidityHistoryPatient's comorbidity history ValueSet
istat-comuneISTAT - Comuni
istat-provinciaISTAT - Province
statoCivileStato Civile
yes-no-unknown-not-applicableYes No Unknown NotApplicable
2.16.840.1.113762.1.4.1021.102Unknown or did not answer
2.16.840.1.113762.1.4.1021.103Other or unknown or refused to answer
2.16.840.1.113762.1.4.1021.24Birth Sex
2.16.840.1.113762.1.4.1240.10Other Unknown Nulls
2.16.840.1.113762.1.4.1240.11Sexual Orientation Including nulls and Data Absent Reason
2.16.840.1.113762.1.4.1240.12Pregnancy Status Observation
2.16.840.1.113762.1.4.1240.2No Healthcare Agent Included Reason
2.16.840.1.113762.1.4.1267.25Detailed race including absence reasons.
2.16.840.1.113883.1.11.10612Unknown Null
2.16.840.1.113883.4.642.2.575Race Categories
2.16.840.1.113883.4.642.40.2.48.1Detailed Ethnicity Including Absence Reasons
2.16.840.1.113883.4.642.40.2.48.3Ethnicity Categories
PolicyStatusPolicyStatus

Resources that this resource uses

No resources found


Narrative

Note: links and images are rebased to the (stated) source

Generated Narrative: CodeSystem v3-NullFlavor

Language: en

Properties

This code system defines the following properties for its concepts

NameCodeURITypeDescription
SpecializesSpecializesCodingThe child code is a more narrow version of the concept represented by the parent code. I.e. Every child concept is also a valid parent concept. Used to allow determination of subsumption. Must be transitive, irreflexive, antisymmetric.
GeneralizesGeneralizesCodingInverse of Specializes. Only included as a derived relationship.
internalIdinternalIdhttp://terminology.hl7.org/CodeSystem/utg-concept-properties#v3-internal-idcodeThe internal identifier for the concept in the HL7 Access database repository.
Statusstatushttp://hl7.org/fhir/concept-properties#statuscodeDesignation of a concept's state. Normally is not populated unless the state is retired..
HL7 Concept Usage NotesHL7usageNoteshttp://terminology.hl7.org/CodeSystem/utg-concept-properties#HL7usageNotesstringHL7 Concept Usage Notes
ParentsubsumedByhttp://hl7.org/fhir/concept-properties#parentcodeThe concept code of a parent concept

Concepts

This case-sensitive code system http://terminology.hl7.org/CodeSystem/v3-NullFlavor defines the following codes in a Is-A hierarchy:

LvlCodeDisplayDefinitioninternalIdStatusHL7 Concept Usage NotesParent
1NI NoInformation

**Description:**The value is exceptional (missing, omitted, incomplete, improper). No information as to the reason for being an exceptional value is provided. This is the most general exceptional value. It is also the default exceptional value.

10610active
2  INV invalid

**Description:**The value as represented in the instance is not a member of the set of permitted data values in the constrained value domain of a variable.

22656activeNI
3    DER derived

**Description:**An actual value may exist, but it must be derived from the provided information (usually an EXPR generic data type extension will be used to convey the derivation expressionexpression .

22657activeINV
3    OTH other

**Description:**The actual value is not a member of the set of permitted data values in the constrained value domain of a variable. (e.g., concept not provided by required code system).

Usage Notes: This flavor and its specializations are most commonly used with the CD datatype and its flavors. However, it may apply to *any* datatype where the constraints of the type are tighter than can be conveyed. For example, a PQ that is for a true measured amount whose units are not supported in UCUM, a need to convey a REAL when the type has been constrained to INT, etc.

With coded datatypes, this null flavor may only be used if the vocabulary binding has a coding strength of CNE. By definition, all local codes and original text are part of the value set if the coding strength is CWE.

10616activeThis flavor and its specializations are most commonly used with the CD datatype and its flavors. However, it may apply to *any* datatype where the constraints of the type are tighter than can be conveyed. For example, a PQ that is for a true measured amount whose units are not supported in UCUM, a need to convey a REAL when the type has been constrained to INT, etc. With coded datatypes, this null flavor may only be used if the vocabulary binding has a coding strength of CNE. By definition, all local codes and original text are part of the value set if the coding strength is CWE.INV
4      NINF negative infinity

Negative infinity of numbers.

10618activeOTH
4      PINF positive infinity

Positive infinity of numbers.

10617activeOTH
3    UNC un-encoded

Description: The actual value has not yet been encoded within the approved value domain.

Example: Original text or a local code has been specified but translation or encoding to the approved value set has not yet occurred due to limitations of the sending system. Original text has been captured for a PQ, but not attempt has been made to split the value and unit or to encode the unit in UCUM.

Usage Notes: If it is known that it is not possible to encode the concept, OTH should be used instead. However, use of UNC does not necessarily guarantee the concept will be encodable, only that encoding has not been attempted.

Data type properties such as original text and translations may be present when this null flavor is included.

22185activeIf it is known that it is not possible to encode the concept, OTH should be used instead. However, use of UNC does not necessarily guarantee the concept will be encodable, only that encoding has not been attempted. Data type properties such as original text and translations may be present when this null flavor is included.INV
2  MSK masked

There is information on this item available but it has not been provided by the sender due to security, privacy or other reasons. There may be an alternate mechanism for gaining access to this information.

Note: using this null flavor does provide information that may be a breach of confidentiality, even though no detail data is provided. Its primary purpose is for those circumstances where it is necessary to inform the receiver that the information does exist without providing any detail.

17932activeNI
2  NA not applicable

Known to have no proper value (e.g., last menstrual period for a male).

10611activeNI
2  UNK unknown

**Description:**A proper value is applicable, but not known.

Usage Notes: This means the actual value is not known. If the only thing that is unknown is how to properly express the value in the necessary constraints (value set, datatype, etc.), then the OTH or UNC flavor should be used. No properties should be included for a datatype with this property unless:

  1. Those properties themselves directly translate to a semantic of "unknown". (E.g. a local code sent as a translation that conveys 'unknown')
  2. Those properties further qualify the nature of what is unknown. (E.g. specifying a use code of "H" and a URL prefix of "tel:" to convey that it is the home phone number that is unknown.)
10612activeThis means the actual value is not known. If the only thing that is unknown is how to properly express the value in the necessary constraints (value set, datatype, etc.), then the OTH or UNC flavor should be used. No properties should be included for a datatype with this property unless: Those properties themselves directly translate to a semantic of "unknown". (E.g. a local code sent as a translation that conveys 'unknown') Those properties further qualify the nature of what is unknown. (E.g. specifying a use code of "H" and a URL prefix of "tel:" to convey that it is the home phone number that is unknown.)NI
3    ASKU asked but unknown

Information was sought but not found (e.g., patient was asked but didn't know)

10614activeUNK
4      NAV temporarily unavailable

Information is not available at this time but it is expected that it will be available later.

10615activeASKU, NAVU
3    NASK not asked

This information has not been sought (e.g., patient was not asked)

10613activeUNK
3    NAVU Not available

Information is not available at this time (with no expectation regarding whether it will or will not be available in the future).

23731activeUNK
4      NAVtemporarily unavailable
3    QS Sufficient Quantity

**Description:**The specific quantity is not known, but is known to be non-zero and is not specified because it makes up the bulk of the material. e.g. 'Add 10mg of ingredient X, 50mg of ingredient Y, and sufficient quantity of water to 100mL.' The null flavor would be used to express the quantity of water.

21436activeUNK
3    TRC trace

The content is greater than zero, but too small to be quantified.

21386activeUNK
1NP not present

Value is not present in a message. This is only defined in messages, never in application data! All values not present in the message must be replaced by the applicable default, or no-information (NI) as the default of all defaults.

10619retired

Source

{
  "resourceType": "CodeSystem",
  "id": "v3-NullFlavor",
  "language": "en",
  "text": {
    "status": "generated",
    "div": "<!-- snip (see above) -->"
  },
  "url": "http://terminology.hl7.org/CodeSystem/v3-NullFlavor",
  "identifier": [
    {
      "system": "urn:ietf:rfc:3986",
      "value": "urn:oid:2.16.840.1.113883.5.1008"
    }
  ],
  "version": "3.0.0",
  "name": "NullFlavor",
  "title": "NullFlavor",
  "status": "active",
  "experimental": false,
  "date": "2019-03-20",
  "publisher": "Health Level Seven International",
  "contact": [
    {
      "telecom": [
        {
          "system": "url",
          "value": "http://hl7.org"
        },
        {
          "system": "email",
          "value": "hq@HL7.org"
        }
      ]
    }
  ],
  "description": "A collection of codes specifying why a valid value is not present.",
  "copyright": "This material derives from the HL7 Terminology THO. THO is copyright ©1989+ Health Level Seven International and is made available under the CC0 designation. For more licensing information see: https://terminology.hl7.org/license.html",
  "caseSensitive": true,
  "hierarchyMeaning": "is-a",
  "content": "complete",
  "property": [
    {
      "extension": [
        {
          "url": "http://terminology.hl7.org/StructureDefinition/ext-mif-relationship-symmetry",
          "valueCode": "antisymmetric"
        },
        {
          "url": "http://terminology.hl7.org/StructureDefinition/ext-mif-relationship-transitivity",
          "valueCode": "transitive"
        },
        {
          "url": "http://terminology.hl7.org/StructureDefinition/ext-mif-relationship-reflexivity",
          "valueCode": "irreflexive"
        },
        {
          "url": "http://terminology.hl7.org/StructureDefinition/ext-mif-relationship-isNavigable",
          "valueBoolean": true
        },
        {
          "url": "http://terminology.hl7.org/StructureDefinition/ext-mif-relationship-relationshipKind",
          "valueCode": "Specializes"
        },
        {
          "url": "http://terminology.hl7.org/StructureDefinition/ext-mif-relationship-inverseName",
          "valueString": "Generalizes"
        }
      ],
      "code": "Specializes",
      "description": "The child code is a more narrow version of the concept represented by the parent code.  I.e. Every child concept is also a valid parent concept.  Used to allow determination of subsumption.  Must be transitive, irreflexive, antisymmetric.",
      "type": "Coding"
    },
    {
      "extension": [
        {
          "url": "http://terminology.hl7.org/StructureDefinition/ext-mif-relationship-symmetry",
          "valueCode": "antisymmetric"
        },
        {
          "url": "http://terminology.hl7.org/StructureDefinition/ext-mif-relationship-transitivity",
          "valueCode": "transitive"
        },
        {
          "url": "http://terminology.hl7.org/StructureDefinition/ext-mif-relationship-reflexivity",
          "valueCode": "irreflexive"
        },
        {
          "url": "http://terminology.hl7.org/StructureDefinition/ext-mif-relationship-isNavigable",
          "valueBoolean": true
        },
        {
          "url": "http://terminology.hl7.org/StructureDefinition/ext-mif-relationship-relationshipKind",
          "valueCode": "Generalizes"
        },
        {
          "url": "http://terminology.hl7.org/StructureDefinition/ext-mif-relationship-inverseName",
          "valueString": "Specializes"
        }
      ],
      "code": "Generalizes",
      "description": "Inverse of Specializes.  Only included as a derived relationship.",
      "type": "Coding"
    },
    {
      "code": "internalId",
      "uri": "http://terminology.hl7.org/CodeSystem/utg-concept-properties#v3-internal-id",
      "description": "The internal identifier for the concept in the HL7 Access database repository.",
      "type": "code"
    },
    {
      "code": "status",
      "uri": "http://hl7.org/fhir/concept-properties#status",
      "description": "Designation of a concept's state.  Normally is not populated unless the state is retired..",
      "type": "code"
    },
    {
      "code": "HL7usageNotes",
      "uri": "http://terminology.hl7.org/CodeSystem/utg-concept-properties#HL7usageNotes",
      "description": "HL7 Concept Usage Notes",
      "type": "string"
    },
    {
      "code": "subsumedBy",
      "uri": "http://hl7.org/fhir/concept-properties#parent",
      "description": "The concept code of a parent concept",
      "type": "code"
    }
  ],
  "concept": [
    {
      "code": "NI",
      "display": "NoInformation",
      "definition": "**Description:**The value is exceptional (missing, omitted, incomplete, improper). No information as to the reason for being an exceptional value is provided. This is the most general exceptional value. It is also the default exceptional value.",
      "property": [
        {
          "code": "status",
          "valueCode": "active"
        },
        {
          "code": "internalId",
          "valueCode": "10610"
        }
      ]
    },
    {
      "code": "NP",
      "display": "not present",
      "definition": "Value is not present in a message. This is only defined in messages, never in application data! All values not present in the message must be replaced by the applicable default, or no-information (NI) as the default of all defaults.",
      "property": [
        {
          "code": "status",
          "valueCode": "retired"
        },
        {
          "code": "internalId",
          "valueCode": "10619"
        }
      ]
    },
    {
      "code": "NAV",
      "display": "temporarily unavailable",
      "definition": "Information is not available at this time but it is expected that it will be available later.",
      "property": [
        {
          "code": "status",
          "valueCode": "active"
        },
        {
          "code": "internalId",
          "valueCode": "10615"
        },
        {
          "code": "subsumedBy",
          "valueCode": "ASKU"
        },
        {
          "code": "subsumedBy",
          "valueCode": "NAVU"
        }
      ]
    },
    {
      "code": "DER",
      "display": "derived",
      "definition": "**Description:**An actual value may exist, but it must be derived from the provided information (usually an EXPR generic data type extension will be used to convey the derivation expressionexpression .",
      "property": [
        {
          "code": "status",
          "valueCode": "active"
        },
        {
          "code": "internalId",
          "valueCode": "22657"
        },
        {
          "code": "subsumedBy",
          "valueCode": "INV"
        }
      ]
    },
    {
      "code": "OTH",
      "display": "other",
      "definition": "**Description:**The actual value is not a member of the set of permitted data values in the constrained value domain of a variable. (e.g., concept not provided by required code system).\r\n\r\n**Usage Notes**: This flavor and its specializations are most commonly used with the CD datatype and its flavors. However, it may apply to \\*any\\* datatype where the constraints of the type are tighter than can be conveyed. For example, a PQ that is for a true measured amount whose units are not supported in UCUM, a need to convey a REAL when the type has been constrained to INT, etc.\r\n\r\nWith coded datatypes, this null flavor may only be used if the vocabulary binding has a coding strength of CNE. By definition, all local codes and original text are part of the value set if the coding strength is CWE.",
      "property": [
        {
          "code": "status",
          "valueCode": "active"
        },
        {
          "code": "HL7usageNotes",
          "valueString": "This flavor and its specializations are most commonly used with the CD datatype and its flavors.  However, it may apply to *any* datatype where the constraints of the type are tighter than can be conveyed.  For example, a PQ that is for a true measured amount whose units are not supported in UCUM, a need to convey a REAL when the type has been constrained to INT, etc. With coded datatypes, this null flavor may only be used if the vocabulary binding has a coding strength of CNE.  By definition, all local codes and original text are part of the value set if the coding strength is CWE."
        },
        {
          "code": "internalId",
          "valueCode": "10616"
        },
        {
          "code": "subsumedBy",
          "valueCode": "INV"
        }
      ]
    },
    {
      "code": "UNC",
      "display": "un-encoded",
      "definition": "**Description:** The actual value has not yet been encoded within the approved value domain.\r\n\r\n**Example**: Original text or a local code has been specified but translation or encoding to the approved value set has not yet occurred due to limitations of the sending system. Original text has been captured for a PQ, but not attempt has been made to split the value and unit or to encode the unit in UCUM.\r\n\r\n**Usage Notes**: If it is known that it is not possible to encode the concept, OTH should be used instead. However, use of UNC does not necessarily guarantee the concept will be encodable, only that encoding has not been attempted.\r\n\r\nData type properties such as original text and translations may be present when this null flavor is included.",
      "property": [
        {
          "code": "status",
          "valueCode": "active"
        },
        {
          "code": "HL7usageNotes",
          "valueString": "If it is known that it is not possible to encode the concept, OTH should be used instead.  However, use of UNC does not necessarily guarantee the concept will be encodable, only that encoding has not been attempted. Data type properties such as original text and translations may be present when this null flavor is included."
        },
        {
          "code": "internalId",
          "valueCode": "22185"
        },
        {
          "code": "subsumedBy",
          "valueCode": "INV"
        }
      ]
    },
    {
      "code": "INV",
      "display": "invalid",
      "definition": "**Description:**The value as represented in the instance is not a member of the set of permitted data values in the constrained value domain of a variable.",
      "property": [
        {
          "code": "status",
          "valueCode": "active"
        },
        {
          "code": "internalId",
          "valueCode": "22656"
        },
        {
          "code": "subsumedBy",
          "valueCode": "NI"
        }
      ]
    },
    {
      "code": "MSK",
      "display": "masked",
      "definition": "There is information on this item available but it has not been provided by the sender due to security, privacy or other reasons. There may be an alternate mechanism for gaining access to this information.\r\n\r\nNote: using this null flavor does provide information that may be a breach of confidentiality, even though no detail data is provided. Its primary purpose is for those circumstances where it is necessary to inform the receiver that the information does exist without providing any detail.",
      "property": [
        {
          "code": "status",
          "valueCode": "active"
        },
        {
          "code": "internalId",
          "valueCode": "17932"
        },
        {
          "code": "subsumedBy",
          "valueCode": "NI"
        }
      ]
    },
    {
      "code": "NA",
      "display": "not applicable",
      "definition": "Known to have no proper value (e.g., last menstrual period for a male).",
      "property": [
        {
          "code": "status",
          "valueCode": "active"
        },
        {
          "code": "internalId",
          "valueCode": "10611"
        },
        {
          "code": "subsumedBy",
          "valueCode": "NI"
        }
      ]
    },
    {
      "code": "UNK",
      "display": "unknown",
      "definition": "**Description:**A proper value is applicable, but not known.\r\n\r\n**Usage Notes**: This means the actual value is not known. If the only thing that is unknown is how to properly express the value in the necessary constraints (value set, datatype, etc.), then the OTH or UNC flavor should be used. No properties should be included for a datatype with this property unless:\r\n\r\n1.  Those properties themselves directly translate to a semantic of \"unknown\". (E.g. a local code sent as a translation that conveys 'unknown')\r\n2.  Those properties further qualify the nature of what is unknown. (E.g. specifying a use code of \"H\" and a URL prefix of \"tel:\" to convey that it is the home phone number that is unknown.)",
      "property": [
        {
          "code": "status",
          "valueCode": "active"
        },
        {
          "code": "HL7usageNotes",
          "valueString": "This means the actual value is not known.  If the only thing that is unknown is how to properly express the value in the necessary constraints (value set, datatype, etc.), then the OTH or UNC flavor should be used.  No properties should be included for a datatype with this property unless:  Those properties themselves directly translate to a semantic of \"unknown\".  (E.g. a local code sent as a translation that conveys 'unknown') Those properties further qualify the nature of what is unknown.  (E.g. specifying a use code of \"H\" and a URL prefix of \"tel:\" to convey that it is the home phone number that is unknown.)"
        },
        {
          "code": "internalId",
          "valueCode": "10612"
        },
        {
          "code": "subsumedBy",
          "valueCode": "NI"
        }
      ]
    },
    {
      "code": "NINF",
      "display": "negative infinity",
      "definition": "Negative infinity of numbers.",
      "property": [
        {
          "code": "status",
          "valueCode": "active"
        },
        {
          "code": "internalId",
          "valueCode": "10618"
        },
        {
          "code": "subsumedBy",
          "valueCode": "OTH"
        }
      ]
    },
    {
      "code": "PINF",
      "display": "positive infinity",
      "definition": "Positive infinity of numbers.",
      "property": [
        {
          "code": "status",
          "valueCode": "active"
        },
        {
          "code": "internalId",
          "valueCode": "10617"
        },
        {
          "code": "subsumedBy",
          "valueCode": "OTH"
        }
      ]
    },
    {
      "code": "ASKU",
      "display": "asked but unknown",
      "definition": "Information was sought but not found (e.g., patient was asked but didn't know)",
      "property": [
        {
          "code": "status",
          "valueCode": "active"
        },
        {
          "code": "internalId",
          "valueCode": "10614"
        },
        {
          "code": "subsumedBy",
          "valueCode": "UNK"
        }
      ]
    },
    {
      "code": "NASK",
      "display": "not asked",
      "definition": "This information has not been sought (e.g., patient was not asked)",
      "property": [
        {
          "code": "status",
          "valueCode": "active"
        },
        {
          "code": "internalId",
          "valueCode": "10613"
        },
        {
          "code": "subsumedBy",
          "valueCode": "UNK"
        }
      ]
    },
    {
      "code": "NAVU",
      "display": "Not available",
      "definition": "Information is not available at this time (with no expectation regarding whether it will or will not be available in the future).",
      "property": [
        {
          "code": "status",
          "valueCode": "active"
        },
        {
          "code": "internalId",
          "valueCode": "23731"
        },
        {
          "code": "subsumedBy",
          "valueCode": "UNK"
        }
      ]
    },
    {
      "code": "QS",
      "display": "Sufficient Quantity",
      "definition": "**Description:**The specific quantity is not known, but is known to be non-zero and is not specified because it makes up the bulk of the material. e.g. 'Add 10mg of ingredient X, 50mg of ingredient Y, and sufficient quantity of water to 100mL.' The null flavor would be used to express the quantity of water.",
      "property": [
        {
          "code": "status",
          "valueCode": "active"
        },
        {
          "code": "internalId",
          "valueCode": "21436"
        },
        {
          "code": "subsumedBy",
          "valueCode": "UNK"
        }
      ]
    },
    {
      "code": "TRC",
      "display": "trace",
      "definition": "The content is greater than zero, but too small to be quantified.",
      "property": [
        {
          "code": "status",
          "valueCode": "active"
        },
        {
          "code": "internalId",
          "valueCode": "21386"
        },
        {
          "code": "subsumedBy",
          "valueCode": "UNK"
        }
      ]
    }
  ]
}